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Summary
Microstereolithography is a method used for rapid prototyping of polymeric and ceramic
components. This technique converts a computer-aided design (CAD) to a three
dimensional (3D) model, and enables layer-per-layer fabrication curing a liquid resin
with UV-light or laser source. However, the use of stereolithography in tissue
engineering has not been significantly explored possibly due to the lack of commercially
available implantable or biocompatible materials from the SL industry. This thesis seeks
to develop a range of new bio-compatible/degradable materials that are compatible with a
commercial 3D direct manufacture system (envisionTEC Desktop). Firstly, development
and modification of microstereolithography equipments were undertaken in order to
allow some understanding on the techniques and the process involved in
microstereolithography technique. Secondly, a selection of multifunctional polymer and
calcium phosphate were studied in order to formulate biodegradable photopolymer resin
for specific tissue engineering applications. A 3D structure was successfully fabricated
from the formulated photocurable resins. They were then sintered at high temperature for
polymer removal, to obtain a ceramic of the desired porosity. Mechanical properties,
morphology and calcium phosphate content of the sintered polymers were characterised
and investigated with SEM and XRD, respectively. The addition of calcium phosphate
coupled with high temperature sintering, had a significant effect on the mechanical
properties exhibited by the bioceramic. The successful fabrication of novel bioceramic
polymer composite with MSL technique offers the possibility of designing complex
tissue scaffolds with optimum mechanical properties for specific tissue engineering
applications.
xiii
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1CHAPTER 1
1.1 Introduction
The human body is supported by the muscoskeletal system. This system provides
form, stability and movement to the human body. It consists of the skeleton (bones),
muscles, tendons, ligaments, joints, cartilage and other connective tissues (Figure
1.1).
Figure 1.1Muscoskeletal system of a human body (www.oursewareobjects.elsevier.com)
Globally, hundred millions of individuals are affected by musculoskeletal conditions,
which make up 2% of the global disease burden and are expected to double by 2020
due to ageing. The primary musculoskeletal dysfunctions include:
i) Osteoarthritis;
ii) Inflammatory arthritis (principally, rheumatoid arthritis);
iii) Back pain;
2iv) Musculoskeletal injuries (such as sports injuries);
v) Crystal arthritis (such as gout); and
vi) Metabolic bone disease (principally osteoporosis).
The United Nations (UN) and the World Health Organization (WHO) have
emphasized that:
(i) Half of the people aged over 65, affected by chronic conditions, suffer of
joint diseases;
(ii) Back pain is the second cause of sick leave;
(iii) The number of osteoporotic fractures has doubled in the last 10 years;
(iv) Severe injuries caused by war and traffic accidents, while increasing the
demand of restorative procedures worldwide, are expected to cost 25% of
health expenses in developing countries by 2010;
(v) Crippling diseases and deformities still distress the normal development of
affected children. The worldwide incidence of bone disorders and conditions
are increasing in those societies where population ageing is combined with
increased obesity and poor physical activity [1].
Table 1.1: The estimated burden of musculoskeletal condition, by gender and region
in 2001 calculated by WHO 2004 [2].
Number of *DALY (thousand)
Total Males Females Developed
countries
Industrial
countriesOsteoarthritis 16,372 6,621 9,750 11,049 5,323
Rheumatoid
arthritis
4,752 1,353 3,404 3,238 1,520
O er
musculoskeletal
condition
8,699 5,033 3,638 6,784 1,880
Total
muscul skeletal
condition
29, 798 13,007 16,792 21,076 8,723
*DALY (disability-adjusted life year) is a composite measure that combines the
number of years lived with a disability and the number of years lost to premature
death.
3This data clearly shows that osteoarthritis has the largest health burden
associated with it. Osteoarthritis is a disorder that affects individual joints such as the
knee or hip, groups of joints such as the hand or the spine in the neck and back, or
combinations of the above. When a joint develops osteoarthritis, some of the cartilage
covering the ends of the bones gradually roughens and becomes thin, the joint doesn’t
move as smoothly and causing pain, stiffness, weakness, joint instability, and reduced
range of motion [3].
Osteoarthritis accounts for the largest portion, 52% of the total burden of
musculoskeletal conditions in developing countries, and 61% of the total burden of
musculoskeletal conditions in industrialized countries. Osteoarthritis is increasing as
the world’s elderly population grows, and is the sixth leading cause of years lost to
disability. In United Kingdom, more than 1 in 50 men aged over 45 years visit their
GP at least once each year, and around 1 in 10 in elderly women. The influence of age
is shown below [4].
Table 1.2: Group of age consulting GP with osteoarthritis [4].
Group (age) Percentage consulting UK estimate
Males:
45 - 64 2% 146,300
65 - 74 6% 136,600
75+ 7% 132,000
Females:
45 - 64 3% 245,300
65 - 74 9% 225,00
75+ 10% 290,100
414,900 males and 760,400 females with OA
Rheumatoid arthritis is an autoimmune disease that causes chronic
inflammation of the tissue around the joint; it affects the limbs more than the spine.
The disorder may result in tiredness, fatigue, weight loss, fever, pain, and disability
4and deformity of the joints. Rheumatoid arthritis has a prevalence of between 1 and 3
% in most countries.
Back pain is extremely common between the ages of 35 and 55, perhaps due
to the nature of occupational hazards in both industrialized and developing countries.
It is estimated that half of workers will experience back pain at some point in their
lifetime, suffering at least one episode each year. Back pain is an important cause of
absence from work, resulting in economic losses. Manual workers are, more likely to
have back problems than white-collar workers since their work is more likely to
involve occupational risk factors, such as poor lifting behaviours.
Table 1.3: Demography age profile of back pain in United Kingdom [4].
Age group (years) Back pain
25 - 34 12%
35 - 44 17%
45 - 54 18%
55 - 64 19%
65 - 74 15%
≥75 15%
Total population 16%
Osteoporosis is caused by low bone mass and deterioration in the bone
structure, which leads to fracture after mild or moderate trauma. The most common
fractures occur in the arms, vertebrae, and hips. Fracture risk increases with age and
has an important impact on quality of life, mortality, and health care costs in most
countries [2].
Nearly three in ten of all those aged over 75 are in chronic pain due to
arthritis.  Based on annual prevalence report on 2006, chronic pain affects at least
10% of population (population study of 5000 people) across all age of groups as
5shown in Table 1.3 [4]. This shows the level of muscoskeletal problem in the adult
UK population is alarming.
Arthritis Research UK, a non-government organisation has provided an
overview of how musculoskeletal condition affects sufferers and the government in
the UK. The overviews are as follow:
• Latest results from Labour Force Survey (LFS) for 2009/2010 indicated that
approximately half a million people in the UK suffered from a musculoskeletal
condition caused or exacerbated by their current or past. Of these, an estimated
248,000 suffered from a disorder mainly affecting their back, 230,000 from a disorder
mainly affecting their upper limbs or neck, and 94,000 mainly affecting their lower
limbs [5].
• A study conducted by Lanyor et. has found that more than 650,000 in the UK
have painful osteoarthritis in one or both hips, three-quarters of whom are aged over
65 [6].
• There are almost 8.5 million people with X-ray evidence of osteoarthritis of
the spine in the UK. Unlike other sites, it is more commonly found in men than
women (by a ratio of 3:2)[7].
• A total of 58,952 primary hip replacements were carried out in England and
Wales in 2006/7. Of these, 94 per cent were due to osteoarthritis and 60 per cent of
these operations were carried out on women [8].
• A total of 62,150 primary knee replacements were performed in England and
Wales in 2006/7. Ninety-seven per cent were due to osteoarthritis and 57 per cent
were performed on women [9].
6• There are around 400,000 adults in the UK with rheumatoid arthritis.
Prevalence is more common in women than men by a factor of 3:1[10].
• The cost to the UK of musculoskeletal conditions is £5.7 billion annually [10].
The estimated cost of these operations total £890 million per year (around £430
million for hip replacements and £460 million for knee replacement) [11].
• Arthritis and back problems are the most common condition for which people
receive Disability Living Allowance (DLA).Total number of people receiving DLA as
a result of arthritis and other musculoskeletal conditions is more than twice that due to
heart and chest disease and stroke combined [8, 12].
1.2 Tissue Engineering
For centuries, the loss or failure of a vital organ or tissue is one of the most
devastating and challenging problems for physician. Transplantation of tissues and
organs from one individual into another is the most fascinating and revolutionary
achievement in the medical field of modern era. It is life saving; thus improving the
health and life quality for millions of people. Transplantation could be divided into
groups; amongst the same species or different species. Figure 1.2 shows the different
types of transplantation.
7Figure 1.2 Schematic illustrations on types of transplantation
Autograft
Tissue transplanted from one part
the body to another in the same
individual.
Example: skin graft, vein
extraction
Allograft
Tissue/organ transplanted two
genetically non-identical members
of the same species.
Example: liver transplant, heart
transplant
Xenograft
Tissue/organ transplant from one
species to an unlike species (or
genus or family).
Example: Porcine heart valve
transplants, skin graft from baboon
8Even though successful transplantations have changed and saved lots of lives,
new problems emerge. Autografts, a tissue transplant from one part of the same
individual to another part, do not invoke any immune reaction but a few case studies
have shown that introducing new tissues on its new location could produce biological
changes because of the abnormal interaction between the tissue. Diverting urine into
the colon can produce fatal colon cancers 20-30 years later while making oesophageal
tubes from the skin can result in skin tumours 30 years later [13].
Allografts, on the other hand, create problems with patients’ immune system
as it attacks the new transplanted tissue/organ due to genetically dissimilarities to the
host, and could result to chronic rejection and destruction over time.  All allograft
patients need to take immunosuppressant drugs for the rest of their lives and an
imbalance of immune surveillance from immunosuppressant can cause new tumour.
These constraints demand new solutions that will be able to provide the needed
tissues [13, 14].
Globally, millions of patients undergo surgeries of organ/tissue transplant and
reconstruction. In the United Kingdom alone, as of 31 March 2010, 10 542 patients
were registered for an organ transplant as shown on Figure 1.3 [10, 15].
9Figure 1.3 Number of deceased donors and transplants in the UK, 1 April 2000 – 31
March 2010, and patients on the active transplant list at 31 March [10, 15].
More than 10 000 people in the UK currently need a transplant. Of these,
1 000 each year – that's three a day - will die waiting as there are not enough organs
available. Figure 1.3 shows that the demand of organ/tissue transplantation is more
than the supply and the trend that persists. The shortages of replacement tissues or
organ transplantations, coupled with the problems of transplantation have resulted in a
significant drive, and need for a new revolutionary approach such as the field of tissue
engineering.
Tissue engineering is a new multidisciplinary field including biochemistry,
cell and molecular biology, genetics, biomedical engineering and materials science.
Tissue engineering uses synthetic or naturally derived engineered biomaterials to
replace damaged or defective tissues such as bone, skin and even organs. William
(2006) has refined the definition of tissue engineering as “the creation (or formation)
of new tissue for the therapeutic reconstruction of the human body, by the deliberate
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and controlled stimulation of selected target cells through a systematic combination of
molecular and mechanical signals” [16].
The fundamental aim of the field is to harvest and seed the donor cell/tissue on
scaffolds (artificial extracellular matrix), induce tissue or organs to restore and
regenerate themselves [17]. Figure 1.4 shows the diagram explaining the basic
principle of tissue engineering.
Donor site Isolated cell Tissue scaffold
Figure 1.4 Basic principle of tissue engineering
Bone substitutes are often required to help repair or replace damaged or
diseased tissues in cases ranging from trauma to congenital and degenerative diseases,
to cancer and to cosmetics. Biomaterials as implants or in medical devices in contact
with the body, have improved the quality of life of many people that have lost a body
Growth
factors/cytokines
in vivo
implantation
In vitro tissue culture
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part or its function. Nowadays, restorative therapies of bone and joint conditions are
commonly treated with autologous and allogeneic transplantations by using autografts
and allografts respectively [18]. However, in treatments using allograft bone, the
recovery rate is lower and the infection rate is higher than with autograft bone. What
more, allograft bone is in limited supply.
1.3 Tissue Scaffolds
Scaffolds are three dimensional supports that are used as a template at the site injury
in guiding cell or tissue growth, in order to regenerate and secrete their own
extracellular matrix and thus assisting the body in growing new, functional tissues.
Scaffolds work in two way, they either helps direct cell growth or simply provide a
shape for the final tissue.
A material that can be used as a scaffold in tissue engineering must satisfy a
number of requirements. Important properties in this regard include biocompatibility
and biodegradation; it should not elicit severe inflammatory responses, and it should
degrade into non-toxic compounds within the time frame required as newly formed
tissue is formed.  The scaffolds should have suitable porosity for cell in-growth, a
surface that balances hydrophilicity and hydrophobicity for cellular attachment, and
mechanical properties that are compatible with those of the tissue as well as maintain
mechanical strength during most parts of the tissue regeneration process. They can be
formulated to contain additives or active agents for more rapid tissue growth or
compatibility. For example, a bone implant may contain a form of calcium phosphate
or a growth factor such as one of the bone morphogenetic proteins [19].
Both natural and synthetics polymers have been extensively researched for the
development of tissue engineering. Chitosan; alginate [20, 21]; collagen [22];
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agarose, fibrin and hyaluronic are some examples of naturally-derived polymers [23].
In the recent years, chitosan has been successfully used in oral and nasal deliveries
due to their mucoadhesive properties. Collagen has been broadly utilised as gene
activated matrices, capable of delivering large quantities of DNA in a direct and
localized manner [24]. Although the preliminary results are promising, concern about
the feasibility of finding large amounts of materials needed for clinical applications
has prompted other researchers to investigate the use of synthetic materials.
Bioceramic scaffolds based on calcium phosphate, are also among the
favoured synthetic materials for bone replacement due to the similar chemical
compositions to the mineral phase of bone and high mechanical strength [25], [26],
[27], [28]. The calcium phosphate family has almost ten members but most materials
are composed of either low solubility hydroxyapatite (HA, Ca10(PO4)6(OH)2) [29],
[29], [30], [31], [32], [33], slowly degradable β-tricalcium phosphate (β-TCP,
Ca3(PO4)2) [29], [30], or degradable dicalcium phosphate dihydrate (DCPD, brushite,
CaHPO42H2O) [31], [32]. These materials are currently used as a stand- alone
materials for bone defect fillers because they do not elicit a foreign body reaction and
are compatible with the host tissues. They are claimed to be osteoconductive, where
bone ingrowths could occur when placed adjacent to normal host bone, and
osteoinductive, meaning they could actively induce the bone formation. However, the
amount of induced bone is very limited [29], [30], [31], [32], [33].
Currently, lots of work has been done to make calcium phosphate ceramic
more osteoconductive by adding growth factors and/or osteoprogenitor cell to the
scaffolds [38], [39]. Although significant research has already been done in these
fields, scientists have yet to produce an ideal tissue scaffolds that can mimic the
human bone entirely.
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The biggest problem faced by scientists is cell attachment to the surface and in
growth into scaffold as they are only able to grow a short distance into the scaffold
because report stated they cannot migrate more than 500µm from the surface [40].
The depth also contributes to the lack of oxygen and nutrient supply to the more in-
depth cells. Botchwey et. al has speculated that high cell density on the exterior of the
scaffold may deplete nutrient supply before these nutrients can diffuse to the scaffold
interior to support tissue growth [41]. The success and ideal design of the tissue
scaffolds is hindered by a few problems listed below; as per reviewed by Chung et. al
[42]:
1. Inability to create vascularised tissue constructs
2. Inability to precisely control the spatial and temporal features of the cellular
microenvironment.
3. The lack of materials with desired functional properties
4. The lack of suitable source of functional cells that is immunologically
compatible with the host.
5. The requirement for large sample volumes, low throughput and slow reaction
time.
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1.4 Fabrication Technique
The fabrication of scaffolds for better tissue regeneration has attracted a great deal of
attention. The fabrication of three-dimensional (3D) scaffolds that mimic the in vivo
cellular microenvironment is of fundamental importance to the success of tissue
engineered constructs. Both scaffold chemistry and architecture can influence the fate
and function of engrafted cells [41], [43], [44], [45], [46].
Most scaffolds in tissue engineering have been fabricated by the traditional
fabrication methods such as gas foaming/salt leaching [39], [40], and freeze drying
[41], [42]. However, these methods do not control the inner/outer architecture, pores,
porosity, and interconnectivity. Rapid prototyping technology has been utilised
extensively because it has the highest fabrication accuracy and with increased number
of material availability, some of the drawback of conventional methods could be
overcome.
Figure 1.5 Biocompatible scaffold structures built on an Envisiontec 3D-Bioplotter
(http://www.deskeng.com/articles/aaawxe.htm, published 1 May 2010).
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Rapid manufacture is a group of technologies that build a three dimensional
(3D) object in layer-by-layer principle. The system is incorporated of computer-aided
design, (CAD) to design a two-dimensional image and transfer to equipment with
different types of technology [51], [52]. There are many ways to classify a rapid
prototyping (RP) technique, one of the ways is categorised based on the prior form of
its materials which are; (1) liquid based, (2) solid based and (3) powder based.
1.4.1 Liquid-based
The starter material for this technique is in liquid form. The liquid is then converted to
solid form through a process known as photo curing [53], [54], [55], [56]. The RP
system within this category include amongst others:
i) StereolithographyApparatus (SLA)
ii) Solid Ground Curing (SGC)
iii) Solid Object Ultraviolet Laser Printer (SOUP)
iv) Microfabrication,
1.4.2 Solid-based
Solid-based RP systems are meant to encompass all form of materials in the solid
state. The solid form can include the shape in the form of a wire, a roll, laminates and
pellets [50, 51]. Some of the RP systems that fall in this category are:
i) Laminated Object Manufacturing (LOM)
ii) Paper Lamination Technology (PLT)
iii) Fused Deposition Modelling (FDM)
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iv) Slicing Solid Manufacturing (SSM)
RP system i) and ii) use cutting and gluing/joining method whereas system iii) and iv)
applied the melting and solidifying/fused method.
1.4.3 Powder-based
Even though powder by itself is in solid state, however, in the RP system it is
specially categorised as powder in grain-like form which use the joining/binding
method [25], [39], [59], [60], [61]. Below is some of the example of RP system that
categorised in this definition:
i) Selective Laser Sintering (SLS)
ii) Three Dimension Printing (3DP)
iii) Electron Beam Melting (EBM)
iv) Direct Metal Deposition (DMD)
In this project, microstereolithography (MSL) has been selected as a means for
the 3-dimensional fabrication of a tissue scaffold. It is the most versatile method with
the highest accuracy and precision to control the matrix architecture such as size,
shape, interconnectivity, branching, geometry and orientation which will yield
biomimetic structures varying in design and material composition.
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1.5 Challenges and Opportunities
Currently, biopolymers in use are based on polyesters such as polycaprolactone (PCL)
or polyhydroacids (PHA), copolymer of lactic and glycolic acid. These materials are
not suitable for the fabrication of scaffold by direct or indirect methods using
stereolithography because they can only be processed by melt or solution techniques.
Generally, only a few monomers, especially acrylic and epoxy-based ones, have the
appropriate photoabsorption characteristic to allow affective stereolithography
photopolymerization to take place. These polymers were never optimised for medical
application in vivo.
The use of stereolithography in TE has not been significantly explored,
perhaps because of the lack of commercially available implantable or biocompatible
materials from the SL industry. On the other hand, polyethylene glycol (PEG) with an
acrylate group is a suitable choice for this kind of rapid prototyping technique. PEG
has characteristic properties such as high hydrophilicity, good tissue biocompatibility,
lack of toxicity and availability of reactive sites for chemical modification whereas
acrylate monomers are known for their high reactivity, which polymerise rapidly in
the present of photogenerated free radicals.
1.6 Research Aim and Objective
Microstereolithography is chosen as a means for the 3D fabrication as it offers unique
ways to precisely control matrix architecture such as size, shape, interconnectivity,
branching, geometry and orientation which will yield biomimetic structures varying in
design and material composition. The use of stereolithography in tissue engineering
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has not been significantly explored, perhaps because of the limitation of commercially
available implantable or biocompatible materials from the stereolithography industry.
The purpose of this project is to develop a range of new bio-
compatible/degradable materials that are compatible with commercial 3D direct
manufacture techniques. There are three stages of development in this project:
1. To develop a stereolithography system for the optimal formulation of
biodegradable photopolymer resin to fabricate 3D scaffolds with controlled
microstructures specifically for soft tissue engineering applications such as hydrogel.
2. To develop a stereolithography system for the optimal formulation of polymer
ceramic resin to fabricate 3D scaffolds with controlled microstructures specifically for
hard tissue engineering applications such as bone.
3. Based on the optimal formulation of photopolymer resin in (1) and (2), the
fabrication of the 3D scaffold is to be fabricated on the commercial
microstereolithography (MSL) apparatus available in the School of Engineering.
It is hoped that we can develop formulations of photopolymer resin that are feasible
and versatile for the specific application such as bones implants and, drug delivery
system. The scaffold fabricated from the new formulation should support biological
cell growth and have a spectrum of mechanical properties. In addition, the findings of
this study could broaden the selection of photopolymer resins which is currently
limited commercially.
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1.7 Thesis Outline
Chapter 1 reviews the research background of the project, such as the materials
development, technology available, comparing their differences and similarities. It
also discusses the aims and objectives of the thesis are then presented.
Chapter 2 and 3 describes the recent development in biodegradable polymer, ceramic
composites, the properties and technology applied during fabrication.
Chapter 4 details the development of the stereolithography system and establishes
parameter by using commercially supply photopolymer resin as controlled sample.
Chapter 5 and 6 reports the analysis and characterisation results for the biodegradable
polymer and polymer ceramic respectively.
Chapter 7 is a preliminary study on the exploration of fabricating ceramic tissue
scaffold via 3D printing. This is to diversify the usage of biomaterials developed
during this study.
Chapter 8 concludes the research and the latest developments are presented to
highlight possible future enhancements.
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CHAPTER 2
Biodegradable Polymer in Tissue Scaffolds
2.1 Introduction
In the recent years, tissue engineering has emerged as an exciting and remarkable
field of research. It is a cross-disciplinary field of biochemistry, cell and molecular
biology, genetics, biomedical engineering and materials science. Tissue engineering
uses synthetic or naturally derived engineered biomaterials to replace damaged or
defective tissues such as bones, skin, and even organs. In tissue engineering,
scaffolding material is the main highlight of the field. The development of scaffold
materials with biodegradable abilities attracts the most attention because they can be
absorbed by the surrounding tissue without surgical removal.
2.2 Biodegradable Polymers
Biodegradable polymers may be made from natural polymers such as corn, wood and
cellulose. They can also be synthesized by bacteria, or small molecules like butyric
acid or valeric acid that provide polyhydroxybutyrate (PHB) and polyhydroxyvalerate
(PHV), as examples. With the development of synthesis studies, biodegradable
polymers could also be derived from petroleum sources or may be obtained from
mixed sources of bio- mass and petroleum [62], [63]. The best known petroleum
sourced biodegradable polymers are aliphatic polyesters or aliphatic-aromatic
copolyesters. Nevertheless, biodegradable polymers that are made from renewable
sources such as polylactides acid (PLA) are demanding the most attention. This is due
to its environmentally friendly origin, in contrast to the fully petroleum-based
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biodegradable polymers [64]. Traditional scaffolds based on biodegradable polymers
such as poly(lactic acid) and poly(lactic acid- co-glycolic acid) are weak and non-
osteoconductive [65].
The polymer matrix may represent the device itself, or can be a scaffold for
cell growth in vitro that is degraded by the growing cells prior to implantation [66].
The device can also be formulated to contain additives or active agents to increase
tissue growth or to improve compatibility. For example, a bone implant may contain a
form of calcium phosphate or a growth factor such as one of the bone morphogenetic
protein. Specific conditions in terms of pH, humidity, oxygenation and the presence
of some metals are required to ensure the biodegradation of such polymers [64].
When the damaged or lost tissue has been successfully replaced by new tissue,
the scaffold will have been completely reabsorbed or become soluble or metabolised
with the by-product eliminated in the body’s metabolic pathways. Consequently, this
eliminates any adverse effect to the human cell tissue or organ associated with the
long-term presence of the foreign material and the need for a second surgery for
implant removal.
2.2.1 Natural biodegradable polymer
There are two major classes of natural polymers; polypeptides and polysaccharides.
Natural polymers are typically biocompatible and enzymatically biodegradable.
Chitosan, alginate, collagen, agarose, fibrin and hyaluronic are some examples of
naturally-derived polymers [20], [67-72] as shown in Table 2.1. In the recent years,
chitosan has been successfully used in oral and nasal delivery due to their
mucoadhesive properties [73-75]. Collagen has been broadly utilised as gene
activated matrices, capable of delivering large quantities of DNA in a direct, localized
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manner [24]. Although the preliminary results are promising, concern about the
feasibility of finding the large amounts of materials needed for clinical applications
has prompted other researchers to investigate the use of synthetic materials.
The main advantage for using natural polymers is that they contain bio-
functional molecules that aid the attachment, proliferation, and differentiation of cells
[23]. Although biodegradable polymers have great potential as scaffolds, some of the
enzymatic degradation may inhibit function, and as a result, the rate of this
degradation may not be easily controlled. Therefore it may be difficult to determine
the lifespan of natural polymers in vivo [23]. Natural polymers are often weak in
terms of mechanical strength due to their brittleness. In addition, low heat distortion,
high gas permeability and low melt viscosity has made the material processing
difficult. Fisher & Bousmina  has introduced cross-linking to these polymers, which
has shown to enhance their structural stability [64].
Table 2.1.Example of biodegradable polymer extensively studied for tissue
engineering application [23].
Natural polymer Synthetic polymer
Agarose
Alginate
Hyaluronic acid
Chitosan
Collagen
Gelatin
Silk
Poly(glycolic acid)
Poly(l-lactic acid)
Poly(d,l-lactic acid-co-glycolic acid)
Poly(caprolactone)
Polyorthoester
Polyanhydride
Polyphosphazene
Polycarbonate (tyrosine derived)
Poly(ethylene glycol)/ Polyethylene oxide
Polyurethane
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2.2.2 Synthetic biodegradable polymer
Biodegradable synthetic polymers offer a number of advantages over other materials
for developing scaffolds in tissue engineering. The key advantages include the ability
to tailor mechanical properties and degradation kinetics. The most common synthetic
polymers are polyesters. Other types include polyanhydride, polycarbonates, and
polyphos-phazenes.
Biodegradable synthetic polymers such as poly(glycolic acid), poly(lactic
acid) and their copolymers, poly(p-dioxanone), and copolymers of trimethylene
carbonate and glycolide have been widely used in a number of clinical applications
due to their degradability and US Food and Drug Administration (FDA) approval
[44], [55], [76-83]. Polyglycolide is widely used for degradable sutures, drug delivery
systems and orthopaedic fixation devices such as pins, rods and screws. Since early
1990s, poly(α-hydroxyl acid) polymers such as polylactide, polyglycolide and their
copolymers (poly(D,L-lactide-co-glycolide) have been investigated as scaffolds for
cartilage tissue engineering [74], [84]. Implants have been fabricated from both
polyglycolides and polylactides. Both the polymers are polyesters and possess an ester
group in the polymer backbone that can be hydrolysed causing chain scission (Figure
2.1).
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Figure 2.1 Hydrolysis and cleavage of the ester linkage
(http://www.uweb.engr.washington.edu/research/tutorials/plagla.html)
The degradation products of these two polymers are glycolic acid and lactic
acid respectively, both of which occur naturally in the body. At high concentrations of
these degradation products, local acidity may increase, resulting in adverse responses
such as inflammation or fibrous encapsulation which the major drawback in the
degradable polymers [85], [86] .
2.3 Mechanism of Degradation
Biodegradable polymers are designed to degrade by two principal ways: (1) passively
by hydrolysis, which is the reaction with water to produce –OH bonds, and (2)
actively by enzymatic oxidation. After implantation, the biomaterial absorbs water
and swells, and degradation will progress from the exterior of the material towards its
interior. The attack of water to the biomaterials initiate the hydrolytic scission of
polymer backbone to form oligomers and finally monomers. During the hydrolysis,
inflammatory cells, particularly leukocytes and macrophages, produce highly reactive
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oxygen species such as superoxide (O2-), hydrogen peroxide (H2 O2), hypochlorous
acid (HOCl), nitric oxide (NO) [85], [87], [88], [89]. The oxidative effect of these
species may cause polymer chain scission and contribute to their degradation. Acids,
bases, salts, or enzymes play a major role in hydrolytic process. As time increases, the
molecular weight of degradation products is reduced by further hydrolysis, which
allows them to diffuse from the bulk material to the surface and then to the solution,
causing significant weight loss [85].
Polymers can be degraded by bulk degradation or surface erosion mechanisms
as shown in Figure 2.2. Bulk degradation is characterized by hydrolysis of chemical
bonds in the polymer chain at the centre of the material, which typically results in an
empty shell but maintains its size for a considerable portion of time. Degradation by
surface erosion mechanism is characterized by loss of the material from the surface
only, resulting in very predictable mass loss profiles [86], [90-94]. The materials get
smaller but keep their original geometric shape. This feature may be beneficial for
delivering molecules at a constant rate and maintaining the mechanical and structural
integrity of the material with degradation. Poly (anhydrides) and poly(orthoesters) are
examples of surface-eroding polymers. All biodegradable polymers contain
hydrolysable bonds, such as glycosides, esters, orthoesters, anhydrides, carbonates,
amides, urethanes, ureas, etc. Polymers with strong covalent bonds in the backbone
(like C-C) and with no hydrolysable groups require longer times to degrade [95].
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(a) Bulk erosion (b) surface erosion
Figure 2.2 Illustration of biopolymer degradation
There are several factors that influence the velocity of the degradation: type of
chemical back bone, pH, copolymer composition and water intake. The most
important factor is the water intake. The water absorption is often related to their
solubility parameter, their glass transition temperature and their degree of crystalinity.
Polyesters based on (-R-COO-)n are often susceptible to hydrolysis. During hydrolysis
of an ester, a carboxylic acid is produced which consequently reduces the pH level
during hydrolysis.  Esters are hydrolysed at a faster rate under acid and alkaline
conditions than they are at neutral pH [96], [97]. If the local pH of the surrounding
microenvironment is reduced below that of the natural physiological pH, an
immunological response is thus elicited. This acidic effect can cause excessive
inflammatory responses, while poor clearance and chronic inflammation associated
with high molecular weight polymers may result in tissue necrosis. Autocatalytic
degradation also causes rapid loss in mechanical strength [84].
While there are several ways to monitor the degradation rate of the
biodegradable polymer, the most important criterion is the molecular weight. Other
types of monitoring that could be used to measure are (1) the loss of mechanical
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strength and (2) complete degradation into monomers or monomer releases. Attempts
to find tissue-engineered solutions as replacement for tissues regeneration have made
the development of new polymers that meet a number of demands is a formidable task
for material scientists.
2.4 Requirement for Tissue Scaffolds
Scaffold is a three dimensional (3D) porous implant that acts as a temporary template
for cell adhesion, proliferation and directs the formation of tissue or organ. A material
that can be used as a scaffold in tissue engineering must satisfy a number of properties
and requirements. These requirements are fundamental as they affect cell survival,
signalling, growth, propagation and reorganization, and also play major roles in
influencing cell shape modelling and gene expression that relate to cell growth and
the preservation of native phenotypes [98].
2.4.1 Biocompatibility
A tissue scaffold should be biocompatible as it should not initiate or promote any
adverse tissue reaction or interrupt other physiological process [99]. These include the
ability to support cell growth and proliferation, as well as the requirement of sufficient
mechanical integrity and strength to withstand manipulations associated with
implantation during tissue regeneration without compromising the scaffold
architecture.
Hydroxyapatite (HAP) is well known to be highly biocompatible and widely
used as tissue culture scaffolding in regenerative medicine. A study on
biocompatibility of ultrathin films of HAP show that the proliferation and
differentiation of cells cultured on the thin layer are 2 to 3 times faster than on
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titanium, and they also show little risk of inflammatory reaction onsite [100], [101].
This shows that culture times on HAP membranes are shorter than with conventional
culture scaffolds. Incompatibility will result in poor cell attachment and inadequate
subsequent tissue generation. Therefore a scaffold should be built with surface that
balances hydrophilicity and hydrophobicity for cellular attachment [102], [103],
[104], [105] .
2.4.2 Biodegradability
The scaffold should be biodegradable and the rate of degradation should be adequate
with the rate of new tissue formation for the controlled release of bioactive molecules.
The rate of enzymatic degradation will depend both on the number of cleavage sites in
the polymer and the amount of available enzymes in the scaffold environment [106],
[107]. As a consequence, the by-product should to be non-toxic, non-stimulatory of
inflammatory cells, and non-immunogenic, which would be detrimental to tissue
regeneration. For example, poly(lactide) acid undergoes hydrolysis scission to
produce lactic acid, then further incorporated in the tricarboxylic acid cycle, and then
excreted by the lungs as carbon dioxide and water. Poly(glycolide) is degraded by
hydrolysis and esterases to glycolic acid. Glycolic acid monomer is either excreted
directly in the urine or enters the tricarboxylic acid cycle [108].
Needless to say, it is important to understand and control both the mechanism
and the rate by which each material is degraded, and to select the perfect choice for
biodegradable polymers with matching mechanical properties, as well as the
degradation rate to the needs of the application.
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2.4.3 Pore size
Another important requirement is the pore size. It must allow appropriate diffusion of
nutrients and metabolites to and from the seeded cell and surrounding tissue. Pore size
has contributed to the progression of osteogenesis due to vascularation. Based on the
previous studies, many researchers have defined scaffold based on size; either micro
for diameters less than 100μm or macro for diameters more than 100μm. The
minimum requirement for pore size was considered to be approximately 100μm, due
to cell size, migration requirement and transport [40]. If the pore size is too small,
pore occlusion can occur in cells, preventing further cell penetration and bone
formation [98], [102], [103], [105], [109]. For colonisation of macropores to occur,
the minimum pore size in which bone will form is claimed to be approximately
100μm. Other researchers have created scaffolds with pore sizes of between 150-
300μm and 500-170μm to promote bone formation [77], [110]. Scaffolds with pore
sizes between 20 and 125 μm have been used for regenerating adult mammalian skin
and 45–150 μm for regenerating liver tissues [98]. Small pores favour hypoxic
conditions and induce osteochondral formation before osteogenesis occurs. In
contrast, scaffold architectures with larger pores rapidly become well-vascularised
and lead to direct osteogenesis [104], [111].
The tissue-type to be implanted on the scaffolds also influences the selection
of pore size. For example scaffolds with pore sizes less than 150μm have been
successfully used for regeneration of skin in burnt patients [50]. Past reports show that
vascular density near the surface of an implanted synthetic membrane was shown to
be highest when membrane pore sizes were between 0.8 and 8.0μm [112]. Whereas
studies using porous chitosan scaffolds observed neovascularisation in scaffolds with
pore size 90 μm [113].
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Research conducted by Chang et.al and Li et. al has shown that osteoblast
appears to exhibit greater cellular response when pore sizes of between 200 and
400μm are employed [35], [40]. This suggests that the curvature of the pore may
provide optimum compression and tension on the cells’ mechanoreceptors and allow
them to migrate into the opening of such size [114].
2.4.4 Interconnectivity of the porous structure
Simultaneously, the incorporation of microporosity within the scaffold materials has
added advantages with regard to pore size. Interconnectivity is a physical
characteristic that aids in the delivery of the physiological nutrients, gases, and the
removal of metabolic waste and by-products from cells that have penetrated the
scaffold [13, 14]. It provides an open porous network structure allowing for easier
vascularisation, which is important for the maintenance of penetrating cells from
surrounding tissues and the development of new bone or tissues in vivo. The higher
the macroporosity, the easier it is for vascularisation to occur. It also ensures the
spatially uniform cell distribution, cell survival, proliferation and migration in vitro
[115].
In-vitro, lower porosity stimulates osteogenesis by suppressing cell
proliferation and forcing cell aggregation. On the other hand, in vivo, higher porosity
pore size results in greater bone in-growth but previous reports show results in low
mechanical properties [116]. Failure to develop an adequate vascular network will
mean that only peripheral cells may survive or differentiate, supported by diffusion.
The degree of interconnectivity may give a greater influence on osteoconduction
instead of the actual size of pores [40].
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High internal surface area to volume ratios is essential in order to
accommodate the large number of cells required to replace or restore tissue or organ
function(s). In addition to the cell attachment, migration and intracellular signalling
are also dependent on the morphology and physiochemistry of the scaffold’s surface
[22], [23].
Taboas et al. successfully incorporated microporosity within a scaffold
material (PLA) consisting of interconnected plate structures, yielding 5-11 μm void
openings, through an emulsion solvent diffusion technique [117]. A scaffold with
adequate microporosity enabled the precondition of bone morphogenetic protein
(BMPs), anti-inflammatory drugs (Dexamethosone), and oxygen releasing agents
(ORAs) such as perflurocarbons on the scaffold [48].
Porosity requirements exceeding 90% and the degree of pore interconnectivity
are fundamental that a scaffold needs to possess a higher degree of interconnectivity
in conjunction with a suitable pore size, in order to minimise diffusion limitations and
pore occlusion. High internal surface area to volume ratios is essential in order to
accommodate the large number of cells required to replace or restore tissue or organ
function(s) [98]. Figure 2.3 clearly illustrates the range of pore size, the relationship
between macroporosity and microporosity, and the interconnectivity of scaffold made
from silk fibron [116].
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Figure 2.3 Pore size gradient across a sponge made of silk fibroin. Pore sizes are
76.3716.2mm (B), 100.7718.2mm (C), 182.0730.0mm (D), 221.3740.6mm (E),
and260.3775.9mm (F). Bar lengths is 10mm (A) and500mm (B–F) [116].
2.4.5 Mechanical performance
Scaffolds should complement the biological and mechanical properties of tissues that
they support. Adequate mechanical performance of a scaffold depends on specifying,
characterizing and controlling the material mechanical properties including elasticity,
compressibility, viscoelastic behaviour, tensile strength and failure strain [74]. Once
the scaffold is produced and implanted, sufficient mechanical strength is important to
manage any in vivo stresses and physiological loadings imposed on the engineered
construct [118].
The formation of tissues with desirable properties depends on scaffold
material mechanical properties at both the macroscopic and microscopic level.
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Macroscopically, the scaffold must bear loads to provide stability to the tissues as it
forms and fulfils adequate perfusion to take place as toxins are removed and nutrients
are replenished. On a microscopic level, evidence suggests that cell attachment,
proliferation, migration and ultimate tissue formation are dependent on mechanical
input to the cells [74]. Hayashi suggested that hard tissue scaffolds should provide a
mechanical modulus in the range of 10-1500 MPa whereas for soft tissue scaffolds, in
the range of 0.4-350 MPa [119].
Table 2.2. Ultimate strength (MPa) and ultimate strain (%) of cortical bone from the
human femur as a function of age [119].
Age (years)
Properties 10-20 20-30 30-40 40-50 50-60 60-70 70-80
Ultimate strength (MPa)
Tension 114 123 120 112 93 86 86
Compression - 167 167 161 155 145 -
Bending 151 173 173 162 154 139 139
Torsion - 57 57 52 52 49 49
Ultimate strength (%)
Tension 1.5 1.4 1.4 1.3 1.3 1.3 1.3
Compression - 1.9 1.8 1.8 1.8 1.8 -
Tension - 2.8 2.8 2.5 2.5 2.7 2.7
2.5 Microstereolithography
Researchers in tissue engineering fields are striving hard to design scaffolds that
mimic the in vivo cellular microenvironment. It is essential to develop materials and
be able to fabricate three dimensional scaffolds with various geometry shapes in order
to achieve this goal. Rapid prototyping is possibly the best technique as it has the
advantage of being able to build objects with predefined macrostructures as well as
controlled multi-scale microstructures.
Rapid prototyping is also known either as solid free-form manufacturing,
computer automated manufacturing, or layered manufacturing. Common and well-
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established rapid prototyping technologies are stereolithography, selective laser
sintering, 3D printing and fused deposition modelling. Of these techniques,
stereolithography is the most versatile method with the highest accuracy and precision
[120]. Most stereolithography systems (SL) and their micro‐versions ‐ MSL)
predominantly work through an additive layer process, where each layer is cured into
a photosensitive resin by a light source in a process called photopolymerization. In
photopolymerization, a source of light such as UV laser or Near IR laser is used to
trigger a chain reaction in the monomer, which induces the polymerization of liquid
monomer into solid polymer [121].
The surface of photosensitive liquid (resin) is exposed to the light source
creating a 2D image on the elevator platform. The first layer is cured, and adheres
onto the plate surface. The elevator descends to a defined distance, and a fresh layer
of resin is spread on top of the 2D object and the light induced solidification of the
next layer is started. This process is repeated layer‐by‐layer by chemical crosslinking
to construct a full 3D structure. The first commercially available layer additive
process of rapid fabrication, directly from computer aided design databases was
produced by 3D Systems in 1987 [98].
Chain  Propagation Chain  Transfer
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laser beam focuses and cures the resin spot by spot. Although spot by spot curing is
time consuming, it can produce a high resolution structure and reduce the spot size to
a few micrometers in diameter, due to the fact that the UV light is focused optimally
onto the resin surface. To obtain these, the position of the surface on which the beam
is scanned has to be precisely and continuously measured, and the focus of the beam
is determined by sufficient precision [124].
The first reported work on a micro 3D structure, using a vector-by-vector
microstereolithography process, was made by N. Nakajima and T. Takagi in 1993.
They demonstrated a constrained surface apparatus (Figure 2.5) that could produce a
3D structure at a resolution 0.8 μm [125]. In the same year, K. Ikuta and K.
Hirowatari showed their apparatus which was able to achieve up to 0.25 μm in XY
direction and 1 μm in the Z direction [126]. They focused the light beam and it
remained fixed, through a transparent window, to trace every layer of the object
vector-by-vector. The x-y translation stages are used to move the entire optical system
to focus the light beam on the surface, or the photoreactor in which the object is made.
The use of a glass window to push on the liquid and obtain a layer of constant
thickness avoids problems related to spreading the fresh resin on the already
polymerised part of the object. However, polymerising through a transparent window
has a major disadvantage: the formed polymer sticks to it, which can result in partial
or total destruction of the part during the manufacturing process [124].
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Figure 2.5 Stereolithography apparatus of Nakajima and Takagi [125].
The free-surface microstereolithography technique was developed to
overcome the adhesion of the polymer to the transparent window; by displacing the
reactor in a three dimensional space by an x-y-z stage [124]. The main disadvantage
of this method is the difficulty in controlling the thickness of the deposited liquid
layer once the liquid layer is spread on the surface. The time required to obtain a
horizontal fresh layer of resin depends on the rheological properties of the resin. Low
viscosity monomers have to be used as often as possible [127].
Photopolymerization is an essential process in MSL. The fabrication
parameters such as exposure energy and layer thickness should be determined
according to the photocurable resin because curing characteristics affect the resolution
of the fabricated object. The intensity distribution of focused light on the resin surface
has an effect on the precision, but the vector-by-vector method has a relatively high
precision because a layer is built by scanning with a very fine beam spot. However,
the integral method generally makes one layer at a time with the use of patterned light
with a cross-sectional image. Therefore, uniform light intensity on the resin surface is
an important factor in projection MSL [128].
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2.5.2 Integral microstereolithography
The next generation of microstereolithography machine known as integral MSL uses
a slightly different technique. In integral MSL, a pattern generator (dynamic
mask/spatial light modulator) is used to shape light, and the modulated light is
transferred through a reduction lens onto the resin surface a reduced feature size
[129]. The layer is cured in one irradiation step by with a high resolution and a certain
depth of focus. This method is significantly faster because a whole layer is cured in a
single process, whereas the vector by vector technique requires every pixel to be
cured one by one.
The first reported use of this technique is by Bertsch et al. in 1995, where they
developed an integral MSL machine using 260 x260 pixel LCD as the UV light mask
[130]. Every pixel of such LCD panels is a small cell that can set either to its
transparent state or to its opaque state, by changing the orientation of the molecules
contained. The insertion of LCD on the optical path of the light beam, makes the
transmitted light modulated, and successfully manufactures complex shape objects in
microstereolithography. The limitation with this technique was the incompatibility
with UV light. In 1998 Laubere et. al has successfully developed an apparatus and a
photosensitive resin reacting with visible light while Chatwin et al used polysilicon
thin film twisted nematic LCD in an integral microstereolithography which operates
in the UV light, transparent to wavelength above 350nm.
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(a) (b)
Figure 2.6 Differential set-up of (a) vector by vector stereolithography and (b)
integral method [127].
The next stage in the development of MSL machine is the use of digital
micromirror device (DMD™) as pattern generator. Figure 2.6 shows the DMD™
developed by Texas Instrument. The pattern generator is an array of micromirrors
actuated by electrostatic forces. The DMD™ is made of 16µm square aluminium
mirrors that can reflect the light in one of two directions. The working principle is
accomplished through electrostatic attraction of rotating mirrors. It is a
microelecromechanical system working as a light switch [131]. In 1999, Bertch
introduced an MSL machine to work with visible light, utilizing DMD technology as
the pattern generator with VGA resolution at 640 x 480. The speed of this machine is
about 200-300 layers per hour, depending on the shape of the layers, and the
resolution is up to 3x3x3 µm3.
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Swiss Federal Institute of Technology in Lausanne has created a
microstereolithography machine which operates in the UV, a DMD™ chip having an
XGA resolution of 1024 x 768. An acrylate-based resin, which highly absorbs the
irradiation wavelengths has been specially formulated for this machine. The
mechanical properties of the resin are close to the conventional stereolithography
resin.
Figure 2.7 Schematic diagram of microstereolithography with digital micro mirror
[127].
One of the major limitations of microstereolithography technology is only that
there are a few choices of photopolymer materials that can be used in this technique.
The polymers are generally acrylates and eventually epoxies. The materials should
also have adequate mechanical, chemical or physical characteristics. The
microstereolithography technique has offered new possibilities of not only as a
prototyping technology, but as a manufacturing technique. The development of new
materials, particular using composite materials made of ceramic particles embedded
in polymer matrix as matrix has attracted lots of attention in the past few years. The
ultimate aim is the production of micro-components in ceramic materials, which can
be obtained by sintering the composite. In order to achieve this, there are a few
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criteria have to be meet such as the load of particles embedded in the resin has to be
sufficiently high. However, this will increases significantly the viscosity of the
chemical media, which the researchers need to address.
2.6 Photopolymerisation
The use of light to initiate and propagate polymerization reaction on a liquid
monomer or macromer has been used extensively in both commercial and clinical
applications. It is a fast and controllable process under ambient or physiological
condition. The sources of light suitable for tissue engineering application are from UV
lamps (330-450 nm, Io: 2-100 mWcm-2) and halogen lamps (400-520 nm, Io: 20-1200
mWcm-2).
Photoinitiators are the main component in the photocurable resin to allow
polymerization. They are responsible for initiating the reaction of polymerization by
producing reactive species upon light absorption. Once the reactive species are
excited, they will generate an induced free-radical polymerisation. Thus only a small
percentage of volume is needed and it is crucial to find suitable photoinitiator with the
accurate concentration.
The photoinniator should posses all the requirements suitable for tissue
engineering applications [1], [132]. They should have:
1. high absorbing capacity for the light used to polymerise to maximize
polymerizable-residue conversion;
2. high photosensitivity, to better match the wavelength of the light to
polymerise or to find spectral window for opaque or pigments
formulation,
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3. fast inniation rates with high inniation efficiency,
4. solubility in aques media,
5. bio-compatibility with cells or molecules entrapped within the forming
polymer, and cells and tissues in the eventuality of body implantation,
and
6. non-toxicity both locally and systematically.
The monomers or macro-monomers in photopolymerizable resins usually have
a photopolymerizable residue that is normally located at one or at both ends of the
molecules.
Recently photopolymerised hydrogels have been investigated for a number of
biomedical applications such as post-operative adhesion formation, drug delivery, and
cell transplantation. Such monomers are poly(ethylene glycol) PEG, with its
derivatives poly (ethelene oxide) (PEO),  poly(vinyl alcohol) (PVA) and its
derivatives,  dimethacrylated poly(lactic acid) b-poly(ethelene glycol)-b-polylactic
acid PLA-b-PEG-b-PLA, PLA-g-PVA, poly(D, L-lactide-co- ε-caprolactone),
modified polysaccarides such as hyaluronic acid derivatives, poly(anhydrides) ,
urethanes , and, diethyl fumarate-poly(propylene fumarate).
Dimethacrylated anhydride monomers were successfully synthesized and
photopolymerized by Anseth et al. in 1997 to produce highly cross-linked polymer
networks. The mechanical properties of the networks were intermediate and
comparable between that trabecular bones but significantly lower than cortical bone.
The polymer networks also show excellent soft tissue compatibility and well tolerated
by the surrounding tissue components [82].
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A photopolymerizing hydrogel system provides an efficient method to
encapsulate cells allowing increased efficiency and uniformity in cell seeding on the
scaffold compared with solid scaffolds. A study done by Ellisseff et al. has
encapsulated bovine and ovine chondrocytes in poly(ethylene oxide)-dimethacrylate
and poly(ethylene glycol) semi-interpenetrating network by the means of
photopolymerization process. Figure 2.8 shows the experimental protocol of cell
photoencapsulate. The findings brings better prospect of photoencapsulation for tissue
engineering and drug delivery purposes [81].
Figure 2.8 Schematic diagram of protocol for photoencapsulation chondrocytes in
poly(ethylene oxide)-based semi-interpenetrating networks in Elisseeff et al. study.
[81].
Lee et al. researchers has successfully optimised biodegradable photopolymer
resin mixtures of poly(propylene fumarate) (PPF) and diethyl fumarate (DEF) for
fabrication in stereolithography with defined  pore sizes, pore shapes, and porosities
as shown in Figure 2.9. In addition, the fabricated scaffold was found to be
44
biocompatible as the cells were able to attach to the scaffold surface and grow after
the cells were fixed and freeze-dried after 4, 7, and 28 days of culture [135].
Figure 2.9 A 3D scaffold prepared from biodegradable photopolymer resin mixture of
poly(propylene fumarate) (PPF) and diethyl fumarate (DEF) [135].
A development further conducted by Choi et al. on the microstereolithography
technique with few modifications on the PPF/DEF formulation, has successfully
fabricated a miniature 3D human kidney scaffold with interconnecting pores (Figure
2.10). Although there were some manufacturing limitations between the samples
when compared to commercial resins, but the developed MSL system and the use of
PPF shows promise for fabricating complex micro-scaffolds with prescribed
microarchitectures [122].
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(a) (b)
Figure 2.10 SEM micrograph of the fabricated kidney scaffold using the (a)
PPF/DEF and (b) commercial resin respectively [122].
Melchels et al. has successfully developed a resin based on poly(D,L-lactide)
macromers and non-reactive diluents via stereolithography technique. The porous and
non-porous hydrogels has narrow pore size distributions, excellent pore
interconnectivity and possessed excellent mechanical properties, similar to those of
linear high-molecular weight PDLLA. They also prepared hydrophobic scaffolds
using a liquid resin based on a 2-armed PDLLA macromer and ethyl lactate. The
clinical study shows mouse pre-osteoblasts showing good cell seeding characteristics,
readily adhered and proliferated well on these networks. This anticipated the
application of these hydrogel structures in tissue engineering, drug delivery, cell-
transplantation and other biomedical applications [78], [136].
2.7 Polyethylene Glycol (PEG)
Polyethylene glycol is widely used in biological application owing to its
biocompatibility, hydrophilicity, and the ability to be chemically tailored and
passively excreted by the body [79]. Hydrogel structures prepared from polyethylene
glycol (PEG)-based resins are suitable to be fabricated with stereolithography because
the photo-reactive and crosslinkable groups like acrylates or methacrylates can be
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easily attached. The photoreactive groups will crosslink the PEG into hydrogen in the
presence of a photoinitiator and upon exposure to UV light. Figure 2.11 shows the
structure of PEG. These hydrogels are permeable to oxygen, nutrients, and other
water-soluble metabolites and have a soft consistency that makes them similar to soft
tissues. PEG-based hydrogels are not bioactive, but the cell-specific bioactivity can be
achieved by covalently attaching adhesion ligands, growth factors, and cytokines to
the hydrogel or by simply trapping the bioactive agents within the hydrogel [137].
Figure 2.11 Structure of poly(ethylene glycol)
A complex three-dimensional (3D) structure was fabricated from
photopolymerizable poly(ethylene glycol) diacrylate (PEGDA) using a commercially
available stereolithography apparatus (SLA). Figure 2.12 shows the schematic
illustration of the modified SLA and experimental protocol for cell
photoencapsulation explored by Chan et al. in 2010. An angiogenic factors, RGDS
peptide sequences were added to the resin which increased cell viability, proliferation,
and spreading compared to pristine PEG hydrogels of the same molecular weight. The
study shows the successful photo patterning of spatial 3D layer-by-
layer and the feasibility of depositing multiple cell types and material compositions
into distinct layers [138].
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Figure 2.12 Schematic illustration of the modified SLA and
experimental protocol for cell photoencapsulation [138].
As mentioned above, the biocompatibility of hydrogel based on PEG was
excellent, even the encapsulation of living cells was made possible during the
fabrication process. Nonetheless, it can be excreted by the kidneys at molecular
weights up to 30 kg/mol [139]. However, the acrylates and methacrylates could create
a non-degradable linear or crosslinked polymer network during photopolymerization,
which are non-desirable in tissue engineering. The modification of backbone of the
polymer by the introduction of degradable chemical bonds in the reactive site of the
monomers such as ester, anhydrides or amide could improve the biodegradability of
the polymer. These amide-based crosslinker may undergo hydrolytic or cleaved
enzymatically in vivo and might be then excreted through glomerular filtration. The
degradation rate also depends on the number and types of degradable chemical bonds
introduced.
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Molecular weight of the monomer and the hydrophilicity or hydrophobicity of
the monomers could also influence the degradability of the tissue scaffolds. In the
tight polymer network of low molecular weight of monomers, the degradation rate is
slow because the degradable chains are hindered due to the density of the crosslinked
network, whereas hydrophobicity will also decrease the degradation rate of the
systems.
A recent study done by Seck et al. in 2010, prepared highly biocompatible
hydrogels that degrade in the body by crosslinking macromers based on block
copolymers of PEG and poly(D,L-lactide) (PDLLA) and built by stereolithography at
high resolutions as shown in Figure 2.13. In contrast to PEG some researchers have
crosslinked PEG with poly(D,L-lactide), a hydrophobic polyester with a glass
transition temperature (Tg) of approximately 55 °C, and, can degrade by hydrolytic
cleavage of the main chain ester bonds. The 3D structures were characterised with
well-defined architectures and good mechanical properties. In addition the porous
hydrogel structures with gyroid pore network architecture showed narrow pore size
distributions, excellent pore interconnectivity and good mechanical properties. The
structures showed good cell seeding characteristics, and human mesenchymal stem
cells adhered and proliferated well on these materials [136].
49
Figure 2.13 Hydrogel with gyroid pore network design built by
stereolithography using PDLLA-PEG-PDLLA based resin [136].
2.8 Conclusion
To date, advances in scaffold fabrication methods have brought brighter and
promising future in the field of tissue engineering. Amongst the majority of
fabrication techniques, rapid prototyping or solid free from fabrication is possibly the
most intriguing and interesting to explore as it offers high resolution of complex 3-D
architectures of materials with tuneable physical properties. Furthermore, the scaffold
is custom-made for patients to the shape of the defect or injury as the defect
information could be obtained from clinical imaging data such as CT, MRI images.
These fabrication techniques allow control over pore architectures, i.e. the pore shape
and size, and perfect pore interconnectivity could be established.  As a result, the
formation has encouraged cell proliferation and tissue regeneration inside the
scaffold.
Biodegradable scaffolds have played an important role in a number of tissue
engineering attempts over the past decade especially in 3D tissue scaffolds. These
scaffolds provide a template for cells to attach, proliferate, and form extracellular
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matrix. The biomaterials must satisfy the following essential property requirement for
scaffolds as listed by Agrawal and Ray [108]:
1. biocompatible,
2. biodegradable or capable of being remodelled,
3. biodegrade in tune with the repair or regeneration process,
4. adequate porosity,
5. highly permeable to allow for proper diffusion,
6. correct pore size for the candidate cells,
7. adequate mechanical properties to provide the correct microstress environment
for cells,
8. provide a surface conducive for cell attachment,
9. encourage the formation of ECM by promoting cellular functions, and
10. able to carry biomolecular signals such as growth factors.
In the past few decades, researches have studied and investigated extensively
on the first five properties listed above; however, for current and future research, a
clear understanding of the latter five parameters is still fundamental and should be
explored vigorously. With the abundance supply of knowledge on fabrication
techniques and biomaterial, a vast opportunity for novel scientific findings and
discovery in tissue engineering field is opened.
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CHAPTER 3
Ceramic Composites
3.1 Introduction to Bones
Skeleton is formed of long bones (eg: femur), flat bones (eg: skull) and cuboids bones
(vertebra and carpals). The primary functions of bones are to provide mechanical
support system for muscular activity and physical protection on organ and soft tissue.
Bone also acts as a storage facility for bone marrow, where red and white blood cells
are harbours. Bone also has an important function of regulating the calcium and
phosphate level in human body system [140], [141].
Bone is a porous material composed of cellular component (35%) and an
extracellular matrix (65%). The cellular component is made of osteoblasts, bone-
forming cells, osteoclasts, bone-destroying cells, and osteocytes, bone-maintaining
cells which are inactive osteoblasts. The extracellular matrix is organic matter that
consists mainly of calcium phosphate, significant amounts of citrate and carbonate
ions and traces of fluoride, magnesium, sodium and collagen.
The unique combination of mineral and tissue in bone has provides excellent
tensile and loading strength. The inorganic mineral phase is responsible for its
stiffness whereas the organic phase (cell and tissue) responsible for maintenance,
tensile strength and elasticity [141].The combination of mineral hydroxyapatite and
collagen matrix gives bone great density and hardness [1], [142]. Figure 3.1 shows the
internal structure of a cancellous bone.
52
Figure 3.1 Structure of internal cancellous bone [143].
There are two types of bones tissues:
1) Cancellous bones
2) Compact /cortical bone
Cancellous bone is characterises with its spongy appearance with numerous
large spaces and it is the most changing and active in growth. It makes up 20 percent
of the human skeleton’s weight and mainly located in large plates and rods known as
trabecular. Cancellous bone also located in vertebral bodies and adjacent to
articulating joint such as the knee joint [144].
Compact bone makes up 80 percent of the weight of a human’s skeleton. They
are stronger as the density is higher than cancellous bones. Compact bone forms a
shell around cancellous bone and is the primary component of the long bones of the
arm, leg and other bones, where its greater strength and rigidity are needed. Even
though compact bones are dense, they are less porous, with a porosity level that
ranges from 5 to 10 percent in comparison to cancellous bone’s 50 to 90 percent
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porosity range. Figure 3.2 shows the different structures of cancellous and cortical
bones.
Despite these differences, compact and spongy bone tissue work together, as
cortical tissue is the shell that covers the cancellous bone of the vertebrae and joint
ends. In addition, the distribution of cortical and cancellous bones varies greatly
between bones; depend on the function of the bone. For instance, the composition of
cortical and cancellous bone in ulna is 92 and 8 percent respectively, whereas typical
vertebra consists of 62 percent cortical and 38 percent cancellous bones [144].
Figure 3.2 Micrograph of a thick ground section on part of the proximal tibia showing
the cortical (compact) bone and the trabecular (cancellous) bone [144].
There are two types of cell that are responsible for bone renewal:
1. Osteoblast
2. Osteoclast
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Osteoblasts are the cells that are responsible for new bone formation. They
also come from the bone marrow and are related to structural cells. They secrete a
collagen rich ground substance essential for later mineralization of hydroxyapatite and
other crystals. The collagen actually strands to form osteoids: spiral fibres of bone
matrix. They control calcium and mineral deposition and are found on the surface of
new bone.
Osteoclasts are large, ruffled edge cells that come from the bone marrow
mononuclear cell. They secrete bone-reabsorbing enzymes that dissolve the bone.
They are found on the surface of the bone mineral next to the dissolving bone.
Osteocytes are cells inside the bone. They also come from osteoblasts that
have been trapped in the osteoids. They are not isolated, however, because they send
out long branches that connect to the other osteocytes.  They play a role in controlling
the extracellular concentration of calcium and phosphate, and are directly stimulated
by calcitonin and inhibited by PTH (Parathyroid hormone).  These cells can sense
pressures or cracks in the bone and help to direct where osteoclasts will dissolve the
bone [141], [145]. Figure 3.3 shows the schematic structure of osteoblast and
osteoclast cells.
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Figure 3.3 Schematic structure of osteoblast and osteoclast cells [145]
3.2 Mechanical Properties of Bone
The mechanical properties of bones are highly dependent on the structure of the bones
as shown Table 3.1. There are also other factors that could give effect to the
mechanical properties of the bone such as:
a) Age of the person
b) Sex of the person
c) Anatomical site
d) Mineral content
e) Amount of water present
f) Disease – e.g. osteoporosis
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Table3.1Mean values for bone modulus of elasticity and ultimate strength [116].
Tensile
strength (MPa)
Compressive
strength (MPa)
Young
Modulus (GPa)
Fracture toughness
(MPa ml/2)
Cancellous bone 7.4 4-12 0.02-0.5 N/A
Cortical bone 60-100 130-180 3-30 2-12
Cartilages 3.7-10.5 N/A 0.7-15.3 N/A
Ligaments 13.46 N/A 0.065-0.541 N/A
Tendon 24-112 N/A 0.143-2.31 N/A
Karageorgiou and Kaplan (2005) has  reported that, the tensile strength and
modulus of elasticity of femoral cortical bone decline by approximately 2 percent per
decade after maturation [116].Table 3.2 shows the effect of age on the mechanical
properties on bone.
Table 3.2: Ultimate strength (MPa) and ultimate strain (%) of cortical bone from the
human femur as a function of age [144], [146].
Structurally, the mechanical properties of bones are determined by the external
and internal architecture of the bone and by the tissue properties [147]. Cortical bone,
for instance, is an anisotropic material; therefore its mechanical properties vary
Properties Age (years)
10-20 20-30 30-40 40-50 50-60 60-70 70-80
Ultimate Strength (MPa)
Tension
Compression
Bending
Torsion
114
-
151
-
123
167
173
57
120
167
173
57
112
161
162
52
93
155
154
152
86
145
139
49
86
-
139
49
Ultimate Strain (%)
Tension
Compression
Torsion
1.5
-
-
1.4
1.9
2.8
1.4
1.8
2.8
1.3
1.8
2.8
1.3
1.8
2.5
1.3
1.8
2.7
1.3
1.8
2.7
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according to the direction of load [145]. For cancellous bone, the mechanical
properties is also determined by the arrangement of the bone material, in addition to
its bone volume fraction [147]. Table 3.3 show how the direction and type of bone
affect the modulus of elasticity and ultimate strength.
Table 3.3 Mean values for bone modulus of elasticity and ultimate strength as studied
by previous researchers [140], [148].
Type of Bone Direction and type of Bone Apparent
Density
(g/cm3)
Ultimate
strength
(MPa)
Modulus of
Elasticity
(GPa)
Cortical
(midfemoral)
Longitudinal tension 1.85 133 17
Longitudinal  Compression 1.85 133 17
Longitudinal shear 1.85 193 17
Transverse tension 1.85 68 3
Transverse compression 1.85 51 11.5
Trabecular
(proximal tibia)
5.3 0.445
Trabecular
(proximal
femoral)
Axial 6.8 0.441
Although bone has its own ability to heal, as the body grows older, this ability
decreases, sometimes due to disease and other factors, and the healing ability is only
limited to small bone defects. Autograft is common for small bone defects. It is
harvested from the patients’ own body and has the advantages of biocompatibility and
immunoresponse. It contains osteogenic cells and osteoinductive growth factors (such
as bone morphogenetic proteins, BMPs), allowing rapid bone regeneration and
reconstruction of bone loss, and is therefore still the “golden standard” and the most-
used bone graft [105]. However, autograft is limited in amount, needs a secondary
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operation, and causes pain and morbidity. Moreover it is not always successful in all
cases.
On the other hand, for larger bone defects, such as excision of bone tumour,
bone sarcoma or other bone diseases, in cases of bone loss in accidents, and in
complicated fractured bones that cannot repair themselves; allograft is required.
However, allografts, pose an increased risk for infection and disease transmission
from the donor. It has osteogenic cells and osteoinductive growth factors as autograft
does, but its osteogenic capacity may decrease due to its immunologic rejection. The
recovery rate is lower because it takes long time to incorporate into the recipient’s
body. In addition, the infection rate is higher, and allograft bone is limited in supply
[66], [149].
The shortcomings of autograft and allograft have encouraged scientists to
develop artificial bone grafts. Biomaterials, such as metals, polymers, calcium
phosphate biomaterials, bioglasses and combinations of thereof, has attracted much
interest, with studies applied clinically for bone repair alone or with the combination
of osteogenic cells or growth factors [116], [150], [151], [152], [153], [154], [155],
[156], [157], [158], [159], [160].
3.3 Ceramics for Bone Tissue Scaffolds
Biomaterials are one of the keystones in tissue engineering research. There are three
most common class of materials used in biomedical materials:
1. Synthetic: metal, polymer, ceramic, composite
2. Naturally derived: plants or animal- derived
3. Semi synthetic or hybrid
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Ceramics are preferred materials as bone grafts because of their superior
properties compare to other biomaterials. Their compositions are similar to natural
bone, low density, high compressive strength, chemical and high wear resistance, and
excellent adherence tissue. Ceramic such as calcium phosphate, silica, alumina,
zirconia, titanium dioxide, and bioactive glass are amongst the extensively studied by
researchers as they are considered biomimetic materials. They stimulate the
formation, precipitation and deposition of calcium phosphate from solution and can
results in enhanced bone tissue formation [38], [161].Calcium phosphate based
scaffolds are used in a wide range of applications in tissue engineering, controlled
drug delivery systems and in the treatment of bone disease [21], [162], [163], [164],
[165].
Table 3.4 shows some of the currents application of other types of ceramics in
medical field. In dentistry, blocks and granules of porous calcium phosphate with
hydroxide-based materials has been used as endodontic filling materials and metal–
ceramic alloys are applied for crowns. Intervertebral disc and joints made from
calcium phosphate-based materials are well known in orthopaedic and ceramics are
used for cranial defect in plastic surgery reconstruction. Characteristics of these
ceramic materials are often high mechanical strength, good body-response and low or
non-existing biodegradability [38], [166], [167].
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Table 3.4 Currents application of other types of ceramics in medical field [38], [162],
[166].
Types of ceramics Current application
Calcium phosphate Bone graft substitutes, surface coating on total joints
replacement
Calcium sulphate Bone graft substitutes
Zirconia Hip implants
Aluminium oxide Hip implants, dental implants, cochlear replacement
Glass Bone graft substitutes, filler for dental materials
Carbon Heart valve coatings, orthopedic implants
Ideally, the characteristics of a biomaterial candidate for bone tissue
engineering should fulfil the following requirements [1], [38], [132], [168], [169] :
1. Biodegradability: resorbed completely by osteoclasts over time, while
osteoblastic activity deposits new mineralised bone at the site
2. Osteoconductivity: ability to activate cellular response to attract osteoclasts
and osteoblasts to the implant site; whilst enhancing the formation of new
living bone
3. Osteoinductivity: ability to stimuli osteoprogenitor cells to differentiate into
osteoblasts that then begin new bone formation.
4. Macroporosity that enables cell ingrowth into the composite
5. Mechanical stability/ease of handling
6. Carrier for growth factors/cells: The most widely studied type of
osteoinductive cell mediators are bone morphogenetic proteins (BMPs).
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Ceramic has slow degradability, which is a hindered property for tissue
engineering purposes but, ceramic or ceramic-derivatives as a scaffold for bone
tissues engineering has a lot of potential to study and explore. This is because of their
osteoconductive properties especially for hydroxyapatite-based calcium phosphate
compounds [40], [170] and bioactive glass [171].To overcome its slow degradability,
whilst improves bone ingrowth, porosity with optimum pore size is introduced to the
implants scaffolds [116].
3.4 Calcium Phosphate Ceramics
Calcium phosphate ceramics were introduced more than 30 years ago as bone
substitutes. Most calcium phosphates are classified as resorbable biomaterials;
meaning under physiological conditions or with placement within the human body;
they will start to dissolve and slowly replaced by advancing tissue such as bone. The
dissolution products are naturally metabolized and they do not induce abnormal
calcium or phosphate levels in urine, serum, or organs [172].
In addition, calcium phosphate biomaterials are also known to be bioactive as
they support bone in-growth and enhance bone tissue formation. Different phases of
calcium phosphate ceramics are used in the modern health care industry depending
upon whether a resorbable or bioactive material is desired.
Calcium phosphates exist in different phases depending on temperature,
impurities and the presence of water [173]. The two phases that are stable at body
temperature are dicalcium phosphate (DCP) and hydroxyapatite (HAP) [174]. HAP
derived from coral or fabricated from synthetic apatite powders, partially decomposes
to β-TCP in a low water environment when heated to about 1200–1300 °C depending
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on the activity of the powder [175].Listed in the Table 3.5 below are some calcium
phosphate compounds of biomaterials interest.
Table 3.5 List of calcium phosphate compounds of biomaterials interest.
Chemical Name Abbr Chemical
Formula
Ca/P
Amorphous calcium
phosphate ACP - - -
Dicalcium Phosphate DCP CaHPO4 Monetite 1.00
Tricalcium Phosphate α-TCP Ca3(PO4)2 1.50
Tricalcium Phosphate β-TCP Ca3(PO4)2 Whitlockite 1.50
Pentacalcium Hydroxyl
Apatite HAP Ca10(PO4)6(OH)2 Hydroxyapatite 1.67
Tetracalcium Phosphate
Monoxide TTCP Ca4O(PO4)2 Hilgenstockite 2.00
3.4.1 Hydroxyapatite
HAP has been one of the main and widely used as bioceramic materials for tissue
engineering purposes.HAP is calcium orthophosphate containing water with a
chemical composition of Ca10 (PO4)6(OH)2. The chemical composition, structure and
mechanical properties are similar to the mineral phase of human bone; the crystalline
form of calcium phosphate ceramic[176]. The ceramics are commercially available in
the form of dense, porous, as granules or blocks (with varying in pore sizes),
porosities, and strengths [177]. Since 30 years ago, blocks and granules of porous
HAP ceramics have been used in orthopaedic, dental or craniofacial surgery[178],
[179].
HAP has been shown to have excellent biocompatibility, because it shows no
sign of toxicity, inflammatory and progenetic response. It also has superior
osteoconductivity, as it can bonds extremely well directly to the host bone and has
good fibrous tissue formation implant between implant and bone[180].Tancred et al.
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successfully made scaffolds from HAP, TCP, and HA/TCP in a ratio of 3:1 that
substantially closer to cancellous bone. The scaffolds are biocompatible and have
excellent osteoconductive properties [181]. Kitsugi et al. showed that the calcium
phosphate ceramics ratio of calcium and phosphate (Ca:P) can be used as bone fillers
for bone defects or bone cavities [182]. Besides HAP ceramics, other calcium
phosphate ceramics including biphasic calcium phosphate ceramic (BCP) and
tricalcium phosphate ceramic (TCP) have been demonstrated to be osteoconductive.
For the past few years, many researchers has also investigates the possibility of HA
and TCP in porous shape to act as tissue engineering scaffolds for cell and drug
delivery [183].
Osteoconductivity is an important property for bone grafting materials,
however, biomaterials may not positively stimulate bone formation as many
researchers have had general thought. Past researchers reported that biomaterials can
only be osteoconductive but not osteoinductive[176], [180], [182], [183]. They are
five complex steps needed in order for the bone formation to occur by osteoinductive
biomaterials [149]:
1) Attachment of mesenchymal cells on material surface,
2) Proliferation and differentiation of mesenchymal cells,
3) Bone matrix formation by induced osteogenic cells,
4) Mineralization of bone matrix and
5) Bone remodelling to form mature bone.
The time for different steps to happen varies with the osteoinductive potentials
of calcium phosphate biomaterials. In 1998, Yuan and fellow colleagues has
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investigated different type of calcium phosphate biomaterials and concluded that
calcium phosphate biomaterials can be osteoinductive when they exhibit specific
chemical and structural characteristics [184].
3.4.2 Calcium Pyrophosphate
Calcium pyrophosphate (CPP) is one of the types of calcium phosphate with a
shortest linear polyphosphate. It is non-toxic and osteoconductive that can form good
bonding with bone [182]. The ratio of calcium to phosphorus ratio (Ca/P = 1.0) is
lower than that of tricalcium phosphate (Ca/P = 1.5) and therefore they are more
soluble[185].  These properties have made it favourable to be evaluated as a possible
bone replacement material.
The mineral phase of CPP is one of the intermediate products in the bio-
mineralisation process and it regulates the onset of calcification in bone [186]. A
small proportion of the total phosphate in normal bone salt occurs in the form of
pyrophosphate ion[187]. Pyrophosphate ions are strong inhibitors of the
crystallization of calcium phosphate. Polyphosphate ions are present in many tissues
throughout the entire body, but they are most highly concentrated in osteoblasts. The
high content of exopolyphosphatases, which split the orthophosphate ions off
polyphosphate compounds, in osteoblast cells indicates that polyphosphate ions have
a large effect on the formation and growth of bone mineral[188].The regulation
process of feedback between alkaline phosphate and membrane plasmatic
glycoproteis is considered to be very important for mineralization of bone[189].
65
3.4.2.1 Preparation of calcium pyrophosphate (CPP)
CPP is prepared through the dehydration and decomposition of brushite by heating
treatment at 800 °C with the release of structural water according to the following
equations[190]:
2CaHPO4·2H2O→ 2CaHPO4 + 4H2O↑ (3.1)
2CaHPO4 → Ca2P2O7 + H2O↑ (3.2)
The transformation of brushite CPP on heating in air can be simplified as below
[188]:
Transformation Temperature (°C)
CaHPO4 . 2H2O → CaHPO4 60–100(in solution or with prolonged storage in
air)
CaHPO4 → α-Ca2P2O7 270–500
α-Ca2P2O7→β- Ca2P2O7 500–750
β-Ca2P2O7→α- Ca2P2O7 1165
CPP has the same structure as potassium dichromate. There are three
modifications of CPP, of which β-Ca2P2O7is tetragonal and α-Ca2P2O7 is monoclinic.
Their crystal structure is shown in Figure 3.4.In the temperature range 700 – 800°C
CPP transforms into the β-Ca2P2O7 modification, this is stable up to at least 1000°C.
Table 3.6 present density value of monoclinic CPP is and tetragonal modification
[188]. According to some data, on cooling, this high-temperature phase of CPP can
remain in the structure of materials containing HAP as a second phase[37].
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Figure 3.4 Crystal structure of β- Ca2P2O7 (a) and α-Ca2P2O7[188].
Table 3.6 Density value of monoclinic CPP is and tetragonal modification[188].
Card No. CPP
Modification Density (g/cm3)
73-440
9-345
33-229
71-212
81-2257
9-346
Monoclinic
Orthorhombic
Tetragonal
Tetragonal
Tetragonal
Tetragonal
2.936
2.950
3.128
3.129
3.127
3.120
3.4.3 Solubility of calcium phosphate compounds
Solubility is one of the most important properties of calcium phosphate. Solubility is
the property of materials to dissolve amount of solid into a unit volume of
homogenous solution. Solubility determines dissolution, precipitation, and hydrolysis
and phase transformation of calcium phosphate. It plays a major role in formation and
resorption of hard tissue and pathological classification. For calcium phosphate, the
solubility is depends on pH changes, temperature and concentration of acids and
bases, such as HCl and NaOH[191].
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While the forming method and exact stoichiometry will have an effect on
solubility, the generally accepted order of solubility is:
ACP > DCP > TTCP > α-TCP > β-TCP >> HAP
Table 3.7 Data on solubility of calcium phosphate [192].
Calcium phosphate Ca: P ratio pH interval SP* at 37°C
Monocalcium phosphate (calcium
dihydrophosphate), Ca(H2PO4)2
0.50 < 1 soluble
Dicalcium phosphate dihydrate
CaHPO4.2H2O
1.00 2-4 10-6.63
Dicalcium phosphate (calcium
hydrophosphate) CaHPO4
1.00 2-4 10-7.02
Octacalcium phosphate
Ca8(HPO4)2(PO4)4.5H2O
1.33 6-7 10-95.9
Hydroxyapatite Ca10(PO4)6(OH)2 1.50-1.67 >5 10-117.2
Amorphous calcium phosphate 1.33 - Not
determined
Calcium pyrophosphate Ca2P2O7 1.00 - -
Tricalcium phosphate (calcium
orthophosphate) Ca3(PO4)2
1.50 - -
Tertracalcium phosphate Ca4P2O9 2.00 - -
*the solubility product (SP) is the product of the concentrations (in respective
degrees) of ions in the solution above precipitate. Thus, for hydroxyapatite
Ca10(PO4)6(OH)2 SP= [Ca2+]10[PO -]6[OH-]2=10-117.2
Hydroxyapatite (HAP) is relative insolubility when compared to the other
calcium phosphate phases as it is the only the calcium phosphate compound that is
stable at pH’s above 4.2. Below this, dicalcium phosphate dihydrate (CaHPO4.2H2O)
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is the stable compound. It is not uncommon for unstable calcium phosphates to
dissolve and reprecipitate as the stable compound at a given pH. Under normal
physiological conditions of pH 7.2, hydroxyapatite is the stable calcium phosphate
compound. This may drop to as low as pH 5.5 in the region of tissue damage,
although this would eventually return to pH 7.2 over a period of time. Even under
these conditions hydroxyapatite is still the stable phase [192]. Table 3.7 shows the
data on the solubility of calcium phosphate.
Recent studies have shown the good osteoconductivity properties of CPP and
improvement in bone mineral content during clinical observation. Kitsugi et al. [182]
produced and implanted bulk dicalcium pyrophosphate ceramic into mature male
rabbits and found the ceramic to be non-toxic and osteoconductive. It was reported
that no fibrous tissue layer was formed at the bone and ceramic interface [182]. ]The
mechanical strength of sintered Ca2P2O7 ceramic was found to improve when a liquid
additive, sodium pyrophosphate (Na4P2O7.10H2O) up to 5 wt%, was implanted in a
New Zealand white rabbit. The bone tissue ingrowth into the macropores of the
ceramic and gradually dissolved over time to be replaced by a bony structure [185],
[193].
Sintered dicalcium phosphate (SDCPP) has been shown to be effective
artificial bone filler for repairing bone defects. Sun et. al (1999) has evaluated the
effect of SDCPP particle size on Newborn Wistar Rat osteoblasts. The addition of
smaller sized SDCP particles (0.5–3.0 and 37–63 µm) into osteoblast culture has
significant affect on the cell counts of osteoblasts and inhibit proliferation of the
osteoblast [189].
69
CPP has also been explored as a possible treatment for osteoporosis, a
common disorder which affects mostly affects elderly women and is characterised by
increase bone resorption relative to bone formation. This occurs generally with an
increase bone turnover. In 2002, Sun et al. has treated ovariectomized rats, a condition
of increased bone turnover and higher bone porosity with sintered dicalcium
pyrophosphate. They found increases in bone mineral content in long bones was
higher and porosity of the trabecular bone was decreased in rats that ingested CPP
than those which ingested alendronate [194]. Successive applications of these
materials depend on the degree of bio-resorption, mechanical strength and bio-
compatibility.
3.5 Ceramic Composite
Another possibility is the use of other materials, like polymers, that are physically or
chemically mixed with a ceramic compound. The fabrication could include
polymer/ceramic blends, precipitating ceramic onto polymer templates, and coating
polymers onto ceramics[117]. Examples of polymers that are commonly used in
combination with ceramics are the polylactic acid-based polymers [195] and
biopolymers like chitosan[196] and collagen[197]. By combining polymer and
ceramic into one composite material, minimize the drawbacks but maintain the
advantages-increase the bioactivity and bio-mimicking of the matrices formed.
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Advantages of polymer.
i) Vast array of polymers available with varying mechanical properties,
degradation times and physical structure. Also the inherent strength and
biomimetic nature of ceramic
ii) Reduce the overall brittleness.
Advantages of ceramic
i) Increase bioactivity and its capacity to take up and deliver factors and
therapeutic substances.
Calcium phosphate cement (CPC) has been extensively studies as bone
replacement for the past decades. To make a CPC, Chen et al. [198] has developed a
calcium phosphate cement (CPC) of tetracalcium phosphate/dicalcium phosphate
anhydrous (TTCP/DCPA)-polyacrylic acid based. The polymer phase is important in
dentistry as luting materials in the composite, as polyacrylic acid is proved to adhere
to tooth mineral or bone and thus could also be applied as biomaterials. The polymer
could also acts as processing aids especially in high shear mixing of, for example,
polypropylene (PP) and TCP. PP could improve the plasticity and processibility of the
composite, as studied by Kalita et al. [173]. The study shows the promising
application of the controlled porosity polymer-ceramic composite scaffolds.
Rhee and Tanaka  has synthesized ceramic nanocomposite compromised of
hydroxyapatite/type II collagen/chondroitin sulfate nanocomposite through a novel
precipitation method [199]. Type II Col has been known to provide specific binding
sites to chondrocyte via integrin and ligand interactions whilst ChS proteoglycan
stimulates chondrocytes adhesion. The nanocomposite may be applicable for use as a
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bone substitute, as it is expected to provide specific binding sites to chondrocyte,
which is vital in bone remodelling.
A novel biodegradable nanocomposite porous scaffold, comprising of β-TCP and
HAP nanofibers were integrated with monomers (acrylamide,
methylenebisacrylamde), was developed by Ramay and Zhang in 2004 [21]. The
inclusion of HAP nanofibers as a second phase in β-TCP porous ceramic has better
mechanical properties than the scaffolds of single-phase calcium phosphate prepared
previously.
A.M. El Kady et al has prepared composites containing CPP powder into the
copolymer matrix containing the grafted chitosan or grafted chitosan–gelatine [200].
They found that the CPP powder had induced a bone-like apatite layer onto the
surface particles. As a result, the compressive strength of the CPP/polymeric
composites was comparable to those of cancellous bone. In vitro test results showed
that CPP/chitosan and/chitosan–gelatine polymeric composites successfully promoted
the formation of apatite onto their surfaces, especially the CPP composites containing
chitosan–gelatine matrices. [200].
3.6 Polymer Ceramic in Microstereolithography
3.6.1 Principle and theory
In ceramic MSL, the photo-curable resin is a combination of monomers,
photoiniatiators and ceramic powders, and is normally called a ceramic suspension.
The green body of polymer ceramic is build when the ceramic particles in the
suspension are bonded by the polymer through UV polymerization. MSL of ceramic
suspension is much more complicated than the MSL of pure polymer. A conventional
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resin is absorbing medium and the attenuation of the light energy with depth can be
accurately modelled with Beer’s Law:
= exp( − ) (3.3)
where:
= energy density
L= depth
ϒ = extinction coefficient
In the ceramic MSL, the light scattering becomes significant when the light
propagates through the highly concentrated ceramics suspension. When a photon
travels through the ceramic suspension, it is scattered by ceramic particles and its
direction of propagation will be changed. Consequently, the photon is absorbed either
by the photo-curable solution or the ceramic particles. The portion of the initial
photons absorbed by the photo-curable solution will initiate the polymerization
reactions. [201].
Curing depth and curing radius are the two critical parameters in MSL. A
dose of light/UV of energy E will cause polymerization to a depth Cd as described by
the Jacob's equation;
= ln[ ] (3.4)
Where is cure depth, is energy density, is depth penetration and,
is critical exposure. Depth penetration, ( ) for the ceramic suspension is controlled
by the particle size (d) an inversely proportioned to the volume fraction (φ) of ceramic
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and strongly dependent on refractive index diffraction between ceramic and the
photo-curable solution (∆ ). is the interparticle spacing and the UV wavelength.
The complexity of the process is shown as the below [202];
∝ φ ∆ (3.5)
Based on the equation above, particle size and the refractive indexes of the
ceramic powder and the solution are additional factors that influence the line width
and the curing depth in ceramic stereolithography. A minimal curing depth and curing
radius are essential to ensure strong bonding within the whole microstructure and to
achieve high spatial resolution [203]. To identify the spatial resolutions of MSL, the
mechanism of light scattering due to the particles suspended in monomer solution is
the most important to determinant.
3.6.2 The influences of the particle size and its distribution on
microstereolithography of ceramic composite
According to the light scattering theory, both particle mean size and distribution affect
light scattering. In a typical ceramic MSL process, the mean size of the ceramic
particles varies from 0.3 to 1 μm. Strong light scattering will occur when the particle
size is close to the wavelength of UV light (0.364 μm) [204]. As the scattering effect
becomes stronger, the incident photons will more likely be scattered into the
surrounding area and consequently, fewer photons can penetrate deeper. The result
suggests that a particle size larger than 0.5 μm is preferred to eliminate the scattering
effect in the ceramic MSL. The scattering effect in ceramic MSL can be greatly
minimized by choosing the ceramic particles that have the refractive index close to
that of the solution [204].
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3.7 Sintering of A Polymer Ceramic
Sintering is an important step in the fabrication process of ceramic bodies, which
involves consolidation of ceramic powder particles by heating the green body to a high
temperature below the melting point. Sintering process may be conducted in different
atmospheres, for example air or an inert atmosphere. The process occurs in three stages: an
initial, intermediate, and final stage. These stages significantly affect the
microstructure and properties of materials. Figure 3.5 shows the illustration of the
sintering stages.
Figure 3.5 Schematic illustrations of stages in sintering process; (i) initial, (ii)
intermediate and (iii) final stage [205].
In the initial stage, the green body of calcium phosphate has a low-density and
is generally lacking in physical integrity. There is a small degree of adhesion between
adjacent particles. Then, the necks begin to form as their vapour-solid interfaces
decreasing at the contact points between the particles. This neck occurs due to the
reduction of surface energy between the particles, in this intermediate stage, hence the
porosity reduced. In the final stage, diffusing happens where the separate particles
start to diffuse to the neghbouring’s powder particles and diminish or even close up
the pores and promote densification of the materials[205]. The degree of porosity
(i) (ii) (iii)
Neck
Ground boundary
Pores
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after sintering is determined by the level of the initial porosity of the green body,
sintering temperature and time. In addition, pore size, porosity and pore size
distribution at the sub-micron level can be controlled by sintering at different
temperatures. Calcium polyphosphate for instance is sensitive to the sintering
temperature; its crystalline phases may be transformed even in a narrow temperature
zone[206]. Past studies has shown that throughout the sintering process, the
amorphous calcium polyphosphate is firstly transformed to γ-CPP, then to β-CPP and
finally is transferred α-CPP. The chronology transformation of the calcium
polyphosphate is shown as following:
( ) 25 – 580°C amorphous γ− ( ) [207]
585– 600°C γ− ( ) [208]
600– 700°C β− ( ) [208]
900– 960°C α− ( ) [209]
During sintering process, linear shrinkage of the ceramic composite is inevitable.
It is distributes by:
i) Loss of polymer in the early stages
ii) Loss of porosity at the sintering temperature
In order to avoid deformation and cracking during polymer removal, to reduce
shrinkage during sintering and to obtain homogenous and dense ceramic pieces after
sintering, the organic concentration in the suspension should be minimized [210].
After sintering, due to the changes on the morphology, the microstructure, phase
composition and phase purity has resulting no improvement of its mechanical
properties [211]. Wang et al. has investigated the effect of sintering time on the
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microstructure, degradability and mechanical property of CPP bioceramics
synthesized by gravity sintering. They have discovered that the that CPP has different
microstructures and properties with relative density, grain size and mechanical
property of CPP increased and the degradation  rate decreased as the sintering time
increased [205], [206].
3.8 Conclusion
The extensive research has been performed in developing better materials for
tissue/bone/organ replacement, which has been the driving force in the tissue
engineering field. The ultimate goal is to find biomaterials that have the mechanical
and physiologic bio-mimicryto fulfil the demands of the host tissue .Calcium
phosphate ceramics are the most common and interesting bioactive materials, due to
their similarity between their surface composition and structure with the mineral
phase of bone.
The major drawback of bioactive ceramics is their low fracture toughness;
brittleness and being non-osteoinductive and non-osteoconductive in nature
.Bioceramics are often used in combination with a biodegradable polymer in order to
find the optimum mechanical and biological performances. Nevertheless, with  the
current activity in materials selection and 3D fabrication, the search for a3D scaffold
with an interconnected pore network of tailored structure, morphology and
mechanical properties suitable for a given application, is looking bright and
promising. It is thus anticipated that the further knowledge gained from this research
will help bring the required technology to the field of tissue engineering.
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CHAPTER 4
The Development of Three Dimensional (3D) Fabrication
Apparatus
4.1. Introduction
A material that can be used as a tissue engineered scaffold must satisfy a number of
requirements. These include biocompatibility, biodegradation to non-toxic products
(within the time frame required for the application), and process ability into
complicated shapes (with desired porosity). Furthermore, the ability to support cell
growth and proliferation and appropriate mechanical properties, including
maintaining mechanical strength during most of the tissue regeneration process.
In this project, microstereolithography has been chosen as a means for the
creation of 3D tissue scaffolds. It offers a unique way to precisely control matrix
architecture including size, shape, interconnectivity, branching, geometry and
orientation, which will yield biomimetic structures varying in design and material
composition. Currently, biopolymers that are in use are based on polyesters such as
polycaprolactone (PCL) or polyhydroacids (PHA), copolymer of lactic and glycolic
acid. These materials are not suitable for the fabrication of scaffolds, by direct or
indirect methods using stereolithography, as they can only be processed by melting or
in solution. On the other hands, polyethylene glycol (PEG) with an acrylate group is a
suitable candidate for this kind of rapid prototyping technique. PEG has useful
characteristic properties, such as high hydrophilic, good tissue biocompatibility, lack
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of toxicity and availability of reactive sites for chemical modification, whereas
acrylate monomers are known for their high reactivity and polymerise rapidly in the
presence of photogenerated free radicals. It produces strong crosslinked bonds
between acrylate groups and has showed promising biocompatibility from cellular
tests [111], [195], [212].
This chapter focuses on the stereolithography apparatus, both commercial and-
in house systems, used in this project. Before deploying a commercial system, some
initial material development was undertaken using existing hardware with the School
of Engineering. This allowed some understanding of the process to be achieved, with
small volumes of test material, before moving to a commercialise setup. The
equipment that was developed in this project were:
1. Light projector and;
2. UV light engine;
This development involved transferring and modification of a non-functional
Envisiontec system and a high power ultra-bright light emitting diode (LED) device,
which emits light at wavelengths similar to the Envisiontec Desktop projector (365
nm).
To benchmark the in-house equipment to the commercial system, a standard
commercial resin (envisionTec’s R11) was used. This would allow characterisation of
layer-by-layer formation and curing process this equipment produced before moving
to new materials. Mechanical characterization of the polymerized samples was also
performed in this study to aid characterisation of the cured resin.  Due to the small
dimension of the built area on the instruments, a Deben Microtensile tester (Deben,
79
United Kingdom) was chosen as a means to measure the tensile strength of the
samples. Soares et al (2008) studies show that dumbbell-shape sample is a suitable
shape for microtensile test, as it improves stress distribution compared to rectangular
and hourglass-shape samples [213]. In these study, different dimension of dumbbell-
shape were prepared in order to find the right dimension with homogeneous stress
distribution tailor-made to the Deben Microtensile tester.
4.2. Development of Light Projector
4.2.1 Materials and methods
A decommissioned Envisiontec Perfactory® Mini was acquired from the Microsensor
and Bioelectronic Laboratory, University of Warwick. The current and well functional
Envisiontec Perfactory® Mini consists of a projector (containing: dynamic mask
modulator (with a DMD chip), visible light source, focusing optics with shutter), a
build platform (photoreactor), a Z‐stage for moving the base (build platform) and an
embedded PC, which allows the system to work independently from the pre-
processing workstation [214]. Out of the non-functional system, the projector was
recovered, which was operational, and deployed in developing new materials. In
addition, the light projector could be fitted into a fume hood cupboard to remove any
issues of exposure to any fumes from the materials.
To ensure that the projector was directly equivalent to the present machine, the
wavelengths of light from both the recovered projector and the present Envisiontec
system were measured with a spectrophotometer (USB 2000+, Ocean Optic, UK) and
compared. As shown in Figure 4.1, the wavelength of the projector was almost
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identical to the present system, though the amplitude was reduced probably due to the
age of the light source within the projector.
Figure 4.1 Spectrum of wavelength between the Envisiontec and
recovered projector.
In order to replicate the working principle of the SLA, some modification had
to be made on the projector. Firstly, the focus point of the light projector was
determined and a steel framework was built. A 60 × 60 mm glass plate was fitted on
top of the steel frame to act as the basement for the machine. This plate was cut from
an old build platform from the Envisiontec Perfactory Mini System. To determine the
focal length of the lens, a piece of paper was placed on the glass plate and the light
focussed through it until a focal point (a dot of focussed bright light) was spotted by
adjusting the height of the steel framework.   The focal length was determined at 35 ±
0.1 cm. Finally, stainless steel mould, with a dimension of 30 × 40 × 30 mm and with
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5 holes of 5 mm in diameter, was fabricated. The mould was used to polymerize the
acrylate in small volumes. Figure 4.2 shows the modified light projector.
(a) (b)
(c) (d)
Figure 4.2 (a) Modification of recovered Envisiontec Perfactory, (b) designed
stainless steel frame, (c) glass basement plate and (d) stainless steel mould for layer
curing determination.
R11 is a photo-reactive acrylate that was chosen as a control material. It is the
standard commercial resin that is used within the Envisiontec systems. It is a liquid,
orange, poly‐methyl‐methyl‐acrylate resin that only requires a high‐pressure mercury
vapour lamp to stimulate photopolymerisation. Table 4.1shows the composition and
properties of R11, as supplied by manufacturer [215].
Power supply
Air vent duct
Stainless steel frame
Glass basement plate
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Table 4.1 Properties of photo-reactive acrylate resin, R11 [215].
Composition (%)
Acrylic oligomers
Dipentaerythritol pentaacrylate
Propoxylated trimethylol propane triacrylate
Photoinitiator
Stabiliser
40-70
0-20
< 5
0.1-0.5
0.1-0.5
Properties
Tensile strength
Elongation at break
Elongation at yield
Flexural Strength
Flexural Modulus
Density
Glass Transmission Temperature
54.0 MPa
3.70 %
7.94 %
87.9 MPa
2250 MPa
1.219 g/cm³
151 °C - 192 °C
About 1 ml of R11 was put into each of 3 holes of the mould and exposed to
the light for 10, 20, 30, 40, 60 and 120 s. After each curing time, the cured resins were
removed and cleaned with isoproponal in a beaker to remove any uncured resin on its
surfaces.  To study the layer controlled of the light projector, Form Talysurf (Taylor
Hobson, UK) was used to measure the thickness of the sample Figure 4.3 shows the
results of sample thickness of R11. An increase in thickness as a function of increased
exposure time was measured. This is expected as the resin, R11, is a highly reactive
photopolymer. In addition, Figure 4.4 shows the colour intensity, as the time of
exposure increased, which is in line with the sample thickness increment.
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Figure 4.3 Sample thickness of Rll versus the time of exposure (average of there
samples).
Figure 4.4The fully cured of R11 resin.
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R11 resin was successfully cured and layer thickness for each time of
exposure was determined. As expected, the thickness of cured resin was increased as
the time of light exposure increased. However, the presence of a photoinhibitor in
R11 limits the total maximum thickness of each layer. Unfortunately, the equipment
has no vertical moving parts, thus cannot be used to form multi-layer structures. The
commercial system contains these moving components. Figure 4.5 show a moving
stage in envisionTec Perfactory Mini.
Figure 4.5 envisiontec Perfactory Mini
Development on formulation of new photopolymer resin is not favourable
with this modified equipment unless a Z-stage or elevator is to be introduced to the
modified machine. Due to time constraint, and lack of knowledge in the
mechanical/electronic field by the author, it was decided to purchase a smaller version
of Envisiontec Perfactory® SXGA+ W/ERM Mini Multi Lens; a Desktop Digital
Shell Printer (Desktop) for materials development purposes. The desktop only
Resin vat
Z stage
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requires a small volume of photopolymer resin; less than 400 cm3 and with some
modification on the resin tray the volume could be reduce to 40 cm3.
Desktop Digital Shell Printer (Desktop) is a rapid manufacturing system
manufactured by envisionTec GmbH, Germany especially for hearing aid
applications. It was purchased to further develop materials for photopolymer
formulation as the modified light projector did not satisfy the project’s objective. The
Desktop is a relatively low cost (sub £30k), easy maintenance and user friendly
machine, using state of the art Digital Light Processing (DLP®) technology from
Texas Instruments®. Figure 4.6 and Table 4.2 show the Desktop available in the
Microelectronic and Biosensor lab, and specification of the machine respectively.
Like most of 3D fabrication, the Desktop has a built in Ethernet interface and can be
connected directly to a PC workstation, and integrated into a network.
Figure 4.6 envisionTec Desktop Digital Shell Printer (Desktop).
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Table 4.2 Specification of the machine extracted from the envisionTec homepage
[218].
Machine properties
Lens system Fixed focal UV lens
Build envelope XYZ (±2mm) 100 x 75 x 100 mm
Native voxel size XY 71 µm
Dynamic voxel thickness Z 25 µm to 150 µm
Resolution SXGA 1400 x 1050 pixel
The Desktop was used as a microstereolithography apparatus for the
fabrication of the formulated photopolymer resin both for soft and hard tissue
applications described in this thesis.
4.3 Optimisation of Test Piece Shape for Mechanical
Characterisation on 600N tensile stage Deben Microtester
4.3.1 Strength of materials
When designing or formulating new materials for any application, the properties and
mechanical characteristics of the materials are very important to investigate. Strength,
hardness, toughness, elasticity, brittleness, and ductility are amongst the mechanical
properties used as measurements of how materials behave under a load. The new
materials are subjected to a wide variety of mechanical tests to measure their strength,
elastic constants, and other material properties as well as their performance under a
variety of actual use conditions and environments. Mechanical tests often involve the
deformation or breakage of samples of material.
Tensile strength is the stress needed for a sample to develop necking and
finally break at the fracture point before it fails. Figure 4.7 shows the engineering
stress-strain curve and illustration of tensile characterisation. Strength is highly
dependent on microstructure because it is proportional to the difficulty of moving
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dislocations through (and between) the grains boundary. The way tensile strength is
measured is dependent upon the type of material. For ductile materials, tensile
strength is measured by their ability to return to its original state in an elastic manner.
The measurement could also apply for permanent deformation after the load has been
removed from the material or until the materials become weakened and brittle after
cyclic loading. For brittle materials, such as ceramic and concrete, the starting point
for a crack or a break in materials is the indication of the tensile strength of the
materials. If one applies a large enough load to a ductile material (of uniform cross-
section) plastic deformation will result in the following (typical) behaviour.
Figure 4.7 A typical stress-strain cure of a material (www.ndt-ed.org)
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The stress-strain behaviour of a material is dependant predominantly on the
strain rate, temperature, and environmental conditions. The tensile stress ( ) on a
material is defined as the force (F) per unit area (A) as the cross-sectional area may
change if the material deforms when subjected to force.
= (4.1)
Whilst strain measures the change in shape of a material when a force is applied.
= ∆ (4.2)
∆ = change in length and = original length.
Since strain is always a ratio of lengths then it is unit-less. Young's modulus is
the slope of stress to strain. It is shown at the initial part of the stress-strain curve
(Figure 4.7) and represents the linear-elastic region. At this region, there is no
permanent deformation if the load is removed. It also is called the modulus of
elasticity or the tensile modulus.
Compressive strength measures the capacity of a material to withstand axially
directed crushing forces and the deformation at various loads. The compressive
strength is calculated from the failure load divided by the cross-sectional area
resisting the load and reported in Megapascal (MPa). Typically, the compression
strength for polymer is higher than in tension while for ceramics it is much larger than
the tensile strength. The test indicates the maximum compressive stress that a material
is capable of developing.
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4.3.2 Mechanical characterisation on Deben Microtester
Microtest modules have been specifically designed to allow real time observation of
the high stress region of a sample with an SEM, optical microscope, AFM or XRD
system. The 600N tensile stage uses standard miniature load cells in the range 2N to
600N was purchased for this project (Figure 4.8). Samples are mounted horizontally,
clamped to a pair of jaws and supported on stainless steel slide bearings. A dual
threaded lead-screw drives the jaws symmetrically in opposite directions, keeping the
sample centred in the field of view.
Figure 4.8 Deben Microtest machine
Mechanical characterization of the polymerized samples was performed to
study the properties of materials after curing. Due to the small dimensions of the built
area on the Desktop, a 600N microtensile stage from Deben, United Kingdom was
purchased for this project as a means to measure the tensile strength of samples.
Microtensile test permit a more homogeneous stress distribution on the mechanical
loading device and the stress distribution is influenced by the test piece shape. Soares
et. al [213] has investigated the effect of stress distribution inside 3 types of testing
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specimen; rectangular, hourglass-shaped, and dumbbell-shaped, all with a 1 mm2
cross-sectional testing region (Figure 4.9). The study shows that dumbbell-shape
sample is a suitable shape for microtensile test as it improves stress distribution
compare to rectangular and hourglass-shape samples [213].
Figure 4.9 Microtensile specimen shape as investigated by Soares et.
al. [213]; (a) rectangular, (b) stick and (c) dumbbell shape.
In these studies, different dimensions of dumbbell-shape were prepared in
order to find the right dimension, with homogeneous stress distribution, tailor-made to
the Deben Microtensile tester.R11 was chosen as the control sample. To find the
optimum size and dimension of the dumbbell shape, ten sets of test pieces with varies
gauge length of 4-6 mm, thickness of 1.5 mm, width 3 mm and length 26 mm were
fabricated and then subjected to tensile test. The optimum design is determine by 2
characterisations:
1.) A good breaking point anywhere along the gauge length as shown in Figure
4.10 and;
2.) Tensile strength is comparable to the properties given by manufacturer; 54
MPa.
(a) (b) (c)
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Figure 4.10 Schematic illustration of acceptable breaking point (marked as dark area).
Stereolithography technique offers free-mould 3D fabrication. The different
gauge length of dumbbell shape was designed with Solidworks 2006, a 3D
mechanical CAD program and saved as ‘STL’ (stereolithography) file. The ‘STL’
files were then transferred to the Desktop. The 3D object is then sliced to 2D layers
using the Desktop application software and manufactured on the Envisiontec
machine. In this system, the DMD has an array of mirrors 1400 x1050with each
mirror measuring 13 μm to define the each shape of specimen. The wave length and
curing time were set to 490nm and 6 sec respectively.
4.3.3 Results and Discussion
Table 4.3 Data collection on microtensile measurement with different gauge length.
Specimen Gauge length
(mm)
Number of test pieces with
acceptable fracture location
Tensile strength
(MPa)
A 4 3 -
B 5 5 27
C 6 7 38
D 7 4 -
*Number of test piece before tensile measurement was 10 pieces.
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Based on Table 4.3, only specimen B and C, were acceptable for tensile
strength measurement as both of these test pieces produced more than 5 specimens
with acceptable fracture locations, compared to the other specimens. Sample C,
showed the highest tensile strength compared to sample B, thus specimens with a 6
mm gauge length appeared to be the optimum length for tensile strength
measurement. Figure 4.10 shows the optimum design of dumb-bell shape for Sample
C.
Figure 4.11 The optimum dumbbell-shape for microtensile characterization.
On the other hand, sample C only satisfied one requirement as an optimum
design for tensile strength measurement i.e. acceptable fracture location. Nonetheless,
the value of tensile strength is still 63% less than the manufacturer’s technical data. In
order to satisfy the second requirement of being the optimum design of dumb-bell
specimen, the curing time during fabrication was prolonged to 9 sec. It is believed that
the longer curing time will strengthen the bonding between each layer. Figure 4.12
represent the stress-strain curve of the dumb-bell shape after exposed to a blue light
pattern for 6, 9 sec for 5 repeatable samples.
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Figure 4.12 Stress-strain curve of R11 for difference time of photocross-linked
exposure tme (5 repeatable samples).
The tensile strength, for the selected design of dumb-bell shape, after 6 sec
and 9 sec of exposure was 38 and 49 MPa respectively. This shows that 9 sec of
exposure time is favourable as it yields a value only 9% off the manufacturer’s value
(54 MPa, this is for a bulk material – not based on a layered process) compared to 6
sec with 30% off manufacturer’s value. These results indicate that 6 sec is insufficient
to fully cure each layer, consequently reducing the amount of polymer branching
during crosslinking between each layer, thus the sample could only attain 0.25%
strain before its failure. Even though, the Young’s moduli for both samples are similar
at 576 MPa, but after 0.15% strain only the samples with 9s of exposure had higher
yield strength.
The evidence is in the increased value of stress for 9 sec samples. The
increment of stress occurs because of strain hardening, when the cross-sectional area
decreases, becoming greater than the increase in load carrying. Further imposed stress
has resulted in strain concentration at the ‘necked’ portion of the sample, indicating
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the failure of the sample. This shows that further curing time, during fabrication,
results in drastic improvement in strength as it corresponds to the fully crosslinking of
the polymer branches.
4.4 Fabrication of Three Dimensional Structures (3D) of
Bioceramic on Enfis UNO AIR LE (Light Engine)
Currently, bioceramics have drawn worldwide interest as a substitute for bone grafts
materials as they have similar composition to natural bone, osteoinductive and
osteoconductive properties, low density, and chemical inertness. Rapid prototyping
techniques such as microstereolithography have an excellent advantage for fabricating
3D tissue engineered structures, i.e. their ability to manufacture predefined
macrostructures or microstructures of complex shapes in shorter time. As discussed in
the previous chapter, they are limited by the number of different photosensitive resins.
This section discussed the design and development of a new MSL apparatus,
employing the Enfis UNO AIR LE also known as “Light Engine”. Here, polymer
ceramic formulation was developed by mixing hydroxyapatite with polymer acrylate.
The designed Light Engine allows development of new resin formulation without the
restrictions of light level, exposure time, photoinhibitor etc. produced by the Desktop.
In addition, it also allows exploring of materials with a lower cross-linking frequency.
Enfis Light Engine (Figure 4.13) is a high power ultra-bright LED device,
which compromise density array up to 100 LEDs within 0.5cm2 apertures. It emits
light wavelength similar to the envisiontec Desktop projector, 365 nm. Table
4.4explained the electro-optical characteristic of the Light Engine
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Figure 4.13 Enfis UNO AIR LE from Enfis, UK or known as Light Engine.
Table 4.4 Electro-optical characteristic of Light Engine as supplied by manufacturer
[219].
Colour Peak wavelength
(nm)
Typical light
output (mW)
Total electrical
power (W)
SUVA
UVA
Violet
Blue
Green
Amber
Red
NIR
Neutral white
365
375
405
465
520
595
630
870
3900-4600K
600
1150
4900
5750
1850
1150
3890
1750
-
18
18
38
38
38
30
30
16
38
4.4.1 Designed of Enfis Light Engine
The basic requirement for a microstereolithography system is:
1. Light source
2. Focusing lens
3. Resin tray
4. Elevator/Z-stage
Figure 4.14 demonstrates the designed light-engine based microstereolithography
apparatus used in this project. The basic frame was built similarly to the designed and
development in the light projector (section 4.2).
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Figure 4.14 Microstereolithography system developed from Enfis Light Engine.
Different to the Light Projector, the Enfis Light engine requires a focusing
lens to control and focus the ultra bright LED, thus the typical microscope lens was
used and stationed on top of the Enfis Light engine, as shown in Figure 4.15. The
length of focal point was determined similarly to the Light Projector method in
section 4.2.
Figure 4.15 Bottom plate of Enfis Engine light system.
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The Z-stage was designed based on a manual elevating system, where 3 pieces
of 10mm ratchet stop micrometer heads were mounted on a stainless steel plate
(Figure 4.16).
Figure 4.16 Close-up on the designed Z-stage
For preliminary study of ceramic polymer resin formulation, only a small
volume resin vat was used. A 100 × 70 mm ×5 mm rectangular tank was made out of
Blue Tack and built on top of a glass plate as shown in Figure 4.17. The ceramic
suspension was then poured in the self-made resin vat.
Figure 4.17 Ceramic suspension resin vat
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A centrifuge tube was cut and its inner wall was covered with aluminium foil
to control and direct the projected light to the glass plate for fabrication (Figure 4.14).
To build a cylinder structure, a circle shape of Al plate (5mm thick with 15mm in
diameter) was fabricated, and strategically stick onto the bottom part of the glass plate
with double-sided tape, right on the path of the projection light.
4.4.2 Polymer Ceramic Test Part
All materials were purchased from Sigma-Aldrich, UK. For this preliminary study,
hydroxyapatite for was chosen as a precursor and mixed with 1, 6 hexanediol
diacrylate, HDDA and 3 wt% 2-benzyl-2-(dimethylamino)-4’-morpholino-
butyrophenone as photoinitiator as shown in Table 4.5.
Table 4.5 Recipe of the ceramic suspension.
Abbreviation Ratio
Monomer 1, 6 hexanediol diacrylate HDDA 10 gram
Ceramic Hydroxyapatite HAP *70 wt %
Photoinnitiator 2-benzyl-2-(dimethylamino)-4’-
morpholino-butyrophenone
PI *3 wt%
*Weight % was based on the mass of the monomer
Every 10 wt% of ceramic powders was added to the HDDA and stirred on a
magnetic stirrer for 15 minutes. This step was repeated until 70 wt% of HAP was
homogenously mixed. The ceramic suspension was kept stirring for 24 hour.
Photoinitiator was added into the ceramic suspension and stirred 1 hour prior
fabrication.
To study the layer control of polymer ceramic during fabrication, the exposing
time was vary from 10 to 60 sec and the methodology of fabrication on Enfis Light
engine has been established as followed:
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1. Ceramic suspension was poured in the resin vat.
2. The switch was turned on for each curing time.
3. After each exposing time, the switch was turned off.
4. After each curing time, the cured resins were removed and cleaned with
isoproponal in a beaker to remove any uncured resin on its surfaces. 3 samples
were repeated for each curing time.
5. The thickness of each cured samples were measured with electronic digital
calliper (± 0.01 mm ).
Table 4.6 Thickness of each cured polymer ceramic (taken from 3 test piece each
time).
Time of exposure time
(sec)
Thickness (mm)
5 0.06
10 0.17
15 0.25
30 0.34
60 0.41
As expected, the thickness increased as the time of curing increased. Figure
4.18 shows the disc manufactured by this instrument, showing that the system worked
correctly and 10 sec curing time was suffice to fabricate a layer of sample as 5 sec
exposure time was too short and the cured layer was too fragile. For the next step, a
3D structure in the shape of cylinder with certain height was expected to be
successfully fabricated with Enfis light engine.
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Figure 4.18 Cured layer of 70 wt% HAP fabricated on Enfis Light engine.
Based on the layer controlled determination, the selected curing time and layer
thickness were 10 sec and 0.20 mm respectively. The methodology for 3D fabrication
was similar to the methodology for controlled layer determination, but with the
introduction of designed Z-stage (Figure 4.16) which plays a major role in fabricating
a 3D structure on Enfis Light engine. Before fabrication, thickness of each layer was
pre-determined by turning the thimble to desired height. The light engine was
switched on for 10 sec and switched off after each layer was cured. The first layer of
polymer ceramic resin was cured and attached onto the Perspex surface, and for the
next layer, the thimble was turned to determined height, the switch was on and the
process was continued until a 3D structure was fabricated. Figure 4.18 shows the
successfully fabricated 15mm height and 15 mm diameter of 70wt% HAP polymer
ceramic.
Figure 4.19 Surface microscopy of 50wt% HAP captured with Veho VMS 001, USB
Digital Microscope, UK.
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By adding a smaller size Al plate (5mm in diameter), a 3D cylinder with 2
different diameters was also successfully fabricated with Enfis Light engine, as shown
in Figure 4.20.
Figure 4.20 A 3D cylinder with different size of diameter.
This opens the opportunity for other researchers to further manipulate and
improve Enfis light engine as a microstereolithography system to fabricate a 3D
scaffolds polymer ceramic composite for hard tissue application. To make the Enfis
Light engine a proper microstereolithography system, the Z-stage need to be
automates; to ease the layer by layer fabrication; and Ethernet interface can be
connected directly to a PC workstation, and integrated in a network to fabricate
custom-made shape and sizes. Currently, the manually adjustable thimbles were
tedious to control and affected the shape and size of the 3D structure.
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4.5 CONCLUSION
In this chapter, the optimisation of sample size and dimension for materials
characterisation on the new Microtensile machine has been presented. Based on this
investigation, the optimum dimension dumb-bell will be standardised for all
measurement in this project, in order to obtain reliable and precise measurements.
Initial work using a decommissioned light projector gave an indication of
possible layer thickness and exposure times, but due to absent an elevator or Z-stage,
a 3D structure with layer by layer fabrication for any shape and sizes could not be
produced. As a result, an envisionTec Desktop machine was chosen as the main
microstereolithography machine for further development of biomaterials in this study.
A second ‘in-house’ instrument was produced based on an Enfis light engine. r. It was
specifically designed to fabricate a 3D structure from formulated photo-curable
ceramic suspensions. The Enfis Light engine has shown the feasibility to fabricate a
3D structure but with further upgrade on the Z-stage and linked with a network, it
could be a good microstereolithography system for photo-curable resin formulation.
Nevertheless, the decommissioned Light projector and Light engine have given
abundance of knowledge and clear understanding on the principle of
microstereolithography techniques.
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CHAPTER 5
The Development of a Biodegradable Polymer for Soft
Tissue Scaffolds
5.1 Introduction
Rapid manufacture is the process of creating a product or part directly from a CAD
(Computer Aided Design) file. This method has developed from the considerable
technical steps achieved in rapid prototyping. One technique of rapid manufacture
(employed here) is the additive layer process. Here a 3D object is sliced into a series
of 2D (cross-sectional) layers, with each of these layers manufactured one after
another, until the 3D part is formed. There are a number of technologies that can
achieve this, these include stereolithography, selective laser sintering, 3-Dimensional
printing, and fused deposition modelling. In this project, microstereolithography
(MSL) was chosen as a means of fabricating 3D tissue scaffolds because of its ability
to produce complex 3D microstructures with geometries and inner structure, like the
cellular structures, as they appear in natural bone and cartilage. It offers a unique
method to precisely control the matrix architecture such as size, shape,
interconnectivity, branching, geometry and orientation, which will allow the
production of biomimetic structures that vary in design and material composition.
Currently biopolymers are based on polyester such as polycaprolactone (PCL)
or polyhydroacids (PHA), a copolymer of lactic and glycolic acid. These materials are
not suitable for the fabrication of scaffolds by direct or indirect methods using
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stereolithography, because they can only be processed by melting or solution
techniques [220]. Generally, only a few special acrylic and epoxy-based monomers
have the appropriate photoabsorption characteristics to allow affective
stereolithography photopolymerization to take place. These polymers were not
developed for medical applications and were created for the rapid prototyping market.
The use of stereolithography in tissue engineering has not been significantly explored,
possibly due to the lack of commercially available implantable or biocompatible
materials from the SL industry.
On the other hand, polyethylene glycol (PEG), with an acrylate group, is a
suitable candidate for this type of rapid prototyping technique. PEG has characteristic
properties such as high hydrophilicity, good tissue biocompatibility, lack of toxicity
and availability of reactive sites for chemical modification, whereas acrylate
monomers are known for their high reactivity, polymerise rapidly in the present of
photogenerated free radicals. It produces strong crosslinked bonds between acrylate
groups and showed promising biocompatibility from cellular test.
The aim of this project is to develop a range of new bio-compatible/degradable
materials that are compatible with a commercial 3D direct manufacture system
(Envisiontec Desktop). It is hoped that we can develop formulations that will support
biological cell growth and have a spectrum of mechanical properties. In order to
achieve this, optimization of the formulation of the photocurable resin was
investigated. This optimisation comprised of:
1. Monomer selection
2. Ratio of photo initiator and inhibitor
3. Mechanical characterisation
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5.2 Formulation of Photopolymer Resin
The basic formulation of photocurable polymers are:
1. Oligomers/monomer/polymer
2. Photoinhibitor
3. Photoinitiator
It is necessary to find a suitable highly reactive monofunctional base monomer
that has lower shrinkage during polymerisation, little swelling of the polymer in the
monomer and offers good mechanical properties. Reactive diluents, either
monofunctional or multifunctional, are needed to aid the processing properties of the
formulation and tuning the network density of the polymer [221]. The network
density of the polymer is dependent on the number of functional groups and on
hydrogen bond formation by hydroxygroups. For instance, by tailoring the chain
length of PEG chains of PEG-diacrylates, the hydrophilicity of the hydrogel could be
tailored [222] and small crosslinkers and monomers with H bonding capacity give
significantly better performance in term of stiffness and strength [220].
Photoinitiators are responsible to initiate the reaction of polymerization by
producing reactive species upon light absorption. Once the reactive species are
excited, they will generate an induced free-radical polymerisation. Photoinniators
operate in the opposite ways; they reduce the excitation during photopolymerisation
to certain curing depths in order to build layer by layer fabrication a success.
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5.2.1 Materials and Methods
Commercially available multifunctional polymers were chosen as precursor in this
study as to show the simplicity of the photopolymer resin preparation.  Table 5.1 lists
all the multifunctional polymers, photoinitiator and photoinhibitor used in the study.
All chemicals were purchased from Sigma Aldrich, UK unless mentioned otherwise.
Table 5.1 List of monomer/polymers for the development of photopolymer resin.
Multifunctional polymer Molecular
weight ( )
Abbreviation
Polyethylene glycol diacrylate 575 PEGDA
Diethylene glycol diacrylate 214 DEGDA
Trietyleneglycol diacrylate 286 TEGDA
1, 6- hexanediolpropoxylatediacrylate 350 HDPA
Dipentaerythritol penta-/hexa-acrylate 524 DPA
Trimethylolpropane triacrylate 428 TMPTA
n-methylpyrrolidone 99 MP
1,6 Hexanediol ethoxylate diacrylate 314 HDeDA
Photoiniatiator
2-benzyl-2-dimethylamino-4’-morpholino-
butyrophenone
PI
Photoinhibitor
Orasol orange (Kremer Pigmente GmbH & Co. KG,
Germany.)
Dye
Figure 5.1 UV Absorption Spectra of 2-benzyl-2-dimethylamino
4’morpholino-butyrophenone (provided by the manufacturer) [223].
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Based on the spectra provided by Perkin –Elmer UV/Vis Lambda 2 (Figure
5.1), 2-benzyl-2-dimethylamino-4’-morpholino-butyrophenone was chosen as a
photoinitiator due to its broad range of absorption and its overlapping with the
wavelength or frequency of the light source of the Light projector (Figure 4.1) [223].
On the other hand, orange Orasol is the inhibitor used in R11, the commercial
photopolymer resin dedicated for envisionTec Perfactory machine.
For the formulation of photocurable resin development, the Light Projector; a
modification, decommissioned EnvisionTec Perfactory® SXGA+ W/ERM Mini Multi
Lens Figure 5.2, (discussed in Chapter 4) is utilised in order to find the suitable
acrylate as a candidate in a formulation with correct amounts of photoiniatiators and
photoinhibitors.
Figure 5.2 Modified envionTec Perfactory® SXGA+ W/ERM Mini Multi Lens.
First, a formulation of 100% diethylene glycol diacrylate, DEGDA was
investigated. The photoinitiator was varied by weight percent (wt %) of polymer from
1.0 – 5% and the dye concentration was kept constants at 0.5 wt% for varying levels
of photoinitiator. The mixture of DEGDA, photoinitiator and dye was measured and
108
magnetically stirred for 1 hour to ensure homogeneity of the solution. The beaker
where the solution was prepared was kept covered with aluminium foil to avoid any
unnecessary photopolymeration from the outside environment.
A few drops of the mixture were then dropped into the cavity of the mould and
exposed for photopolymerisation by the light projector from 5 to 20s (Figure 5.3).
There were 5 samples for each exposing time.
Figure 5.3 Illustration of photopolymerisation of photocurable resin.
Photopolymer resin
Stainless steel mould
Glass plate
Light projector
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Figure 5.4 envisionTec Otoflash Post Curing System..
After each exposure, the cured samples were then picked from the glass plate,
and cleaned with isopropanol to remove uncured polymer. The cleaned polymers were
post-cured with an EnvisionTec Otoflash Post Curing System for 50 flashes (Figure
5.4).  To study the effect of photoinitiator on the layer control of the
photopolymerised formulation, the thickness of each sample was determine with
Form Talysurf (Taylor Hobson, UK).
To study the degradation behaviour of the hydrogel, swelling ratio for cured
polymers were monitored. Past studies has shown that the molecular weight of the
PEG repeating unit in the macromer affected the hydrogel swelling ratio and as a
result affect the mechanical properties of the hydrogel [224]. The swelling occurs
when a polymer network is in contact with an aqueous solution or biological fluid and
reach thermodynamic compatibility between the polymer chains and water [225]. The
swelling ratios of the gels were determined by measuring the weight of the swollen
gels after 24 hours in pH 7.4 buffer solutions at 37 °C and the weight of the dried gels
(5 samples each formulation). Hydrogel composites were transferred to PBS and
cultured statically at 37 °C for 4 weeks. At day 1, 7, 14, 21, and 28, the swelling ratio
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and sol fraction of DEGDA hydrogel composites were then determined by the
following equations [3, 4]:
= − (5.1)
= − (5.2)
where = Weight of dried hydrogel composites after cross-linking;
= weight of hydrogel composites after swelling in PBS, and;
= weight of dried hydrogel composites after swelling.
The swelling ratio is defined as the fractional increase in the weight of the
hydrogel due to water absorption. The sol fraction represents the fraction of the
polymer following a cross- linking reaction that is not part of a cross-linked network.
A decrease in sol fraction over time reflects polymer loss and characterizes the extent
of hydrogel degradation.
10 pieces of dumbbell shape for each formulation were fabricated on the
desktop and were then subjected to micro-tensile measurement. The measurement was
done with Deben Microtest machine with motor-speed of 0.05 mm/min. The elastic
modulus (E) of the sample was calculated using the slope of the stress (σ) vs. strain
(λ) curve from the strain limit to the first 10% [138].
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5.2.2 Results and Discussion
5.2.2.1 Layer control determination
During polymerization of 100% DEGDA, it was difficult to get a good sample for
thickness measurement. Most of the samples were either partly crosslinked or with a
sol-gel state, furthermore if the samples were in a solid form there were not stiff
enough for thickness measurement. There were not concrete conclusions on which
variables effect the curing of 100% DEG-DA.
Figure 5.5 100%DEG-DA after cured.
Table 5.2 Thickness measurement for 100 DEGDA, 50:50 DEG-DA: DPA-DHA and
80:20 DEG-DA: DPA-DHA.
Photoinitiator
Concentration (wt
%)
Time of
Exposure
(s)
Thickness (µm)
100:0
DEGDA
50:50
DEGDA:DPA
80:20
DEGDA:DPA
1.0
10 No cured samples/ partly crosslinked
2.0
3.0
4.0
5.0
1.0
15 No cured samples/ partly crosslinked
2.0
3.0
4.0
5.0
1.0
20
No cured
samples/
partly
crosslinked
No cured samples/ partly
crosslinked2.0
3.0 125.07 145.69
4.0 133.34 148.66
5.0 158.61 180.54
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Due to the inconsistency of the variables and unacceptable sample for
thickness measurement, new compositions of photopolymers were investigated; 50%
DEG-DA : 50% DPA-DHA and 80% DEG-DA : 20% DPA-DHA.  Dipentaerythritol
penta/ Hexa-acrylate, DPA was added in the prepolymer of DEG-DA to give
increased rigidity and so allow for better layer formation.
Figure 5.6 shows the cured polymer resin after increasing the exposure time.
The thickness for both compositions was still higher and not as expected because the
objective of the study was to get a control layer of 50µm less than 10 seconds of
exposure time (Table 5.2). This requirement is necessary in order to fabricate new
photopolymer resin on envisionTec Perfactory equipment available in the Engineering
as the Z-build thickness of the machine is only 50 µm. Even though the initial studies
were unsuccessful, but the knowledge and the experience in formulating new
photopolymer resin on modified equipment has given author some understanding on
the principles and process involved in the microstereolithography technique.
(a) (b)
Figure 5.6 The polymerized composition of (a) 50:50 DEG-DA: DPA-
DPA and (b) 80:20 DEG-DA-DPA.
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5.3 Development of Photopolymer Resin on Desktop Digital Shell Printer
(Desktop).
Development on formulation of new photopolymer with the decommissioned
EnvisionTec Perfactory® SXGA+ W/ERM Mini Multi was not possible due to the
unsatisfactory results above. In order to formulate a new photopolymer, the
experiments were continued on the envisionTec Desktop Digital Shell Printer
(Desktop), which is a smaller version of Envisiontec Perfactory® SXGA+ W/ERM
Mini Multi Lens (Figure 5.7).
Figure 5.7 envisionTec Desktop Digital Shell Printer (Desktop).
Table 5.3 shows the recipe for new photopolymer resin for materials
development on the desktop and the sample preparation was described previously.
3.75 wt% photoinitiator and 0.15 wt% dye for each formulation were added to each
formulation.
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Table 5.3 Formulation of multifunctional acrylate for photopolymer resin.
Sample Monomer/polymer Ratio (%)
A DEDGA
HDPA
90
10
B DEDGA
HDPA
80
20
C TEGDA
HDPA
90
10
D PEGDA
HDPA
80
20
For swelling ratios determination, 5 disks (6 mm diameter, 1 mm thick) of
each formulation were fabricated in the Desktop machine. The swelling ratios (Q)
were measured from these gel disks and the swelling ratio is shown in Table 5.4.
Elastic modulus for sample B was omitted, due to failure during micro-tensile
measurement.
5.3.1 Results and Discussion
During measurement, the samples were broken outside the breaking gauge as
discussed in Chapter 4.
Table 5.4 Swelling ratios measurement for each cured polymer. ( 5 test pieces
for each cured polymer; ± standard deviation).
Sample Swelling ratio, Q Elastic Modulus, E (kPa)
A
B
C
D
6.5 ± 0.2
7.1 ± 0.3
8.4 ± 0.2
10.8 ± 0.4
10.39 ± 0.2
-
3.70  ± 0.3
1.61 ± 0.2
As expected, the swelling ratios (Q) increased and elastic modulus (E)
decreased as the acrylate functional group increased. During photopolymerisation, the
free radicals recombine caused by the chains of polymers cross-linking together and
as a result, increasing the molecular mass of the polymer. Past studies have shown
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that molecular weight and concentration of macromer, and cross-linker and initiator
can influence the swelling ratio of a cross-linked composite. Theoretically, as the
molecular weight of the cured polymer increases, the spacing between the cross-links
becomes larger and therefore the resulting hydrogel will have a larger mesh size,
exhibited by a higher swelling ratio [224].
Figure 5.8 Sol fraction of cured polymer after immersion in PBS for up to 28 days.
The data was taken from 5 samples for each formulation. Error bars represent the
standard deviation for each measurement.
The sol fraction of the samples over times is shown in Figure 5.8. For each
formulation, there was little decreased percentage in sol fraction. These results show
that the polymerised formulation exhibit degradation properties, which is a vital
requirement for a biomaterial. Nevertheless, these results promise potential for the use
of this resin for soft tissue scaffold applications.
Furthermore, it is interesting to note that the different multifunctional acrylates
and the ratio of photopolymer resins have not affected the tensile strength of the cured
polymer, as shown in Table 5.5.
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Table 5.5 Tensile strength of polymer fabricated from different type of
multifunctional acrylate resin. The standard deviation obtained from five data for each
formulation.
Samples Tensile strength (kPa)
A 13 ± 0.1
C 14 ± 0.1
D 12 ± 0.1
These results were attributed by the inconsistent of the fabricated dumb-bell.
They had reproducibility problem because their successfully fabricated yield was low,
shape-defect (distortion and warping) and delamination. Figure 5.9 shows a fabricated
dumb-bell test piece for micro-tensile measurement. Here, the delamination of the
sample can be seen clearly seen.
.
Figure 5.9 Delamination occurred on the dumb-bell test piece fabricated on the
envisionTEC Desktop.
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5.4 Development of Glycopolymer Resin on Desktop Digital Shell Printer
(Desktop).
Even though the mechanical properties of the cured polymer were not promising, they
were sufficient to allow the exploration/functionalization of these resins by
investigating the addition of a carbohydrate groups to the polymer system for
biomedical application of hydrogels.
Hydrogels are hydrophilic, which explains their swelling properties and their
capability of maintaining encapsulated cell viability. Unfortunately, they are also a
poor environment for cell attachment and proliferation, which is unfavourable in en
vivo applications. Currently, glycopolymers have attracted a lot of attention from the
materials science community due to their biocompatibility and their bioactivity for
applications in tissue engineering and targeted drug delivery systems.
Glycopolymers are synthetic polymers with pendant carbohydrates, which if
the carbohydrate displays on the cell surface, it can play critical a role in cell-cell
recognition, adhesion and signalling between cells [226]. For instance; saccharide units
in glycopolymers can be capable of molecular recognition and interact with specific
carbohydrate receptors. The participation of saccharides in biological recognition has
led to the development of glycosylated drug and gene delivery carriers in which the
carbohydrate receptors are used to direct the drugs to specific organ or cell targets and
of carbohydrate-sensitive biosensors to monitor saccharide molecular recognition
processes. Due to their excellent biocompatibility, glycopolymers have been proposed
for use as scaffold materials in tissue engineering, while sugar-based hydrogels, are
attractive as biocompatible water-absorbent materials [227]. In addition they also play
an important role in cell growth regulation, differentiation, adhesion, cancer cell
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metastasis, cellular trafficking, inflammation by bacteria and viruses, and immune
responses [228].
There are two ways of synthesising glycopolymers; protected and unprotected
carbohydrates. There are two major linkages by which carbohydrate chains can be
attached to proteins: either N-linked through an asparagines residue or O-linked
through a threonine or serine. A given glycoprotein may contain only N-linked, only
O-linked, or both types of oligosaccharide chains [229]. The choice of employing
protected or unprotected sugars is dependent on the ease of stereospecific
functionalization of the sugar, the solubility of the monomer and polymer, the
potential incompleteness of the removal of the protective group, and the ease of
purification [228]. In this study, the synthesis of glycopolymers synthesis with
unprotected carbohydrate and was done in collaboration with a researcher from
Department of Chemistry, Warwick University. The synthesis was done according to
Ohno et. al. method (1990) and explained as following section.
5.4.1 Preparation of PEGDA/HDPA-GlcAc
5.4.1.1 Synthesis of 1,2,3,4,6-Penta-O-acetyl-beta-D-glucopyranose; Acetyl
2,3,4,6-tetra-o-acetyl-beta-D-glucopyranoside (GlcAc)
Figure 5.10 Molecular structure of 1, 2, 3, 4, 6-Penta-O-acetyl-beta-
D- glucopyranose; Acetyl 2, 3, 4, 6-tetra-o-acetyl-beta-D-
glucopyranoside (GlcAc) (http://www.chemblink.com/products/604-
69-3.htm).
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The synthesis was made by a slight modification of the method proposed by
Ouchi et al. [230]. Dry acetone, triethylamine, and acryloyl chloride was added drop
wise at 0 °C to cold solution of 1,2,3,4,6-Penta-O-acetyl-beta-D-glucopyranose. The
mixture was magnetically stirred for 1 hour at 0 °C and then for another 2 hours at
room temperature. The system was diluted with cold water and extracted three times
with chloroform. The combined extracts were dried over anhydrous sodium sulfate.
After the solvent was evacuated, the crude product was purified by flash silica gel
chromatography with a 2:3 (v/v) hexane/ ethyl acetate mixture as an eluent to yield
pale yellow syrup. Crystallization of the syrup was induced in cold hexane to give a
slightly yellow powder.
5.4.1.2 Deprotection of GlcAc
The protected polymer was dissolved in 80% formic acid and stirred for 48 hours at
room temperature, to which water was added and stirred for another 3 hours. The
solution was dialyzed against distilled water for 2 days, concentrated in vacuo, and
finally lyophilized to give GlcAc as a white powder in quantitative yield. Table 5.6
shows the final formulation of the glycopolymers as a photopolymer resin.
Table 5.6 Formulation of glycopolymers photopolymer resin
Sample Ratio (%)
PEGDA HDPA GlcAc
Control
2.5Glc
5.0Glc
70.0
72.5
70.0
30.0
25.0
25.0
-
2.5
5.0
To study the effect of introducing carbohydrate onto the acrylate branches, the
glycopolymers were subjected to swelling ratio and microtensile measurements. The
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methodologies for both measurements were described in section 5.2.1 and 4.3.2
respectively.
5.4.2 Results and Discussion
Table 5.7 Swelling ratios measurement for each glycopolymers. ± is the standard
deviation of three five data obtained at each formulation.
Sample Swelling ratio, Q Elastic Modulus, E (kPa)
Control
2.5Glc
5.0Glc
9.9 ± 0.1
11.8 ± 0.2
13.2 ± 0.2
9.84 ± 0.5
8.70  ± 0.3
5.62 ± 0.2
Table 5.7 represents the swelling ratios measurement for each formulation.
Swelling studies indicated that the addition of the glycopolymer has a significant
effect on the swelling ratio after 24 hours. As a comparison, the swelling ratio has
increased 20 and 33% after 2.5 and 5.0 % of GlcAc was added to the PEGDA/HDPA.
The modification and increases of GlcAc has increased the molecular weight of the
polymer mixture and as a result increases the swelling ratio of the cured polymer. The
ability to absorb water and coupled with optimum rate of degradation are amongst the
main characteristics required in a drug delivery system. Sol fraction of the material
explained the degradation rate of the cured glycopolymers. Figure 5.11 represents the
degradation behaviour of glycopolymers after immersion in PBS for 1, 7, 14, 21 and
28 days.
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Figure 5.11 Sol fractions of glycopolymers after immersion in PBS for up to 28 days.
The error bars is the standard deviation of five data obtained at each soaking time.
The engineered carbohydrate based materials has significant effect on the
degradation rate of the cured glycopolymers. As a comparison, the rate of degradation
has decreased 33% after 5.0% of GlcAc was branched onto the acrylate backbone and
immersed for 28 days in the SBF solution. This results show the role of
polysaccharide in promoting the hydrolytic scissioning of the polymer backbone
hence increased the degradation rate.
However, sugar-based glycopolymers has no significant effect on the tensile
strength of the cured polymers as shown in Figure 5.12. These results were related to
the shape of fabricated dumb-bell from the gycopolymers resin; which was still not
optimal. The sample showed delamination and warping, a sign of stress after post-
curing.
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Figure 5.12 Tensile strength of glycopolymers with different ratio of GlcAc. The error
bars is the standard deviation of five data obtained at each soaking time.
Figure 5.13 shows the surface morphology analysis on sample 5.0 Glc and the
control sample after fabrication. The morphology clearly shows the differences
between the two specimens. The control sample has a smooth and less contaminated
surface (Figure 5.13 (a)) whereas the sample with 5.0% GlcAc has induced more
stress post-curing, which promotes delamination and uneven surface (Figure 5.13(b)).
Further magnification on the SEM (Figure 5.13 (c)), shows the gap of
delamination was about 50µm and the surface roughness shows brittleness of the
sample which explained the low tensile strength. Bartolo et. al indicated that as  the
differences between the temperature within the irradiation volume and the
surrounding resin that can produce stress gradients [231]. These suggest that the
fabrication needs to be in a controlled environment, which is very interesting to
explore in the future
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Figure 5.13 Surface morphology of (a) control sample, (b) 5.0% Glc with 100x
magnification and (c) 5.0 Glc with 500 x magnifications.
5.5 Conclusion
In this study it was shown that it was possible to synthesize a new photopolymer resin
with different type of multifunctional acrylate polymer that compatible with a
microstereolithography technique. However, the hydrogels suffered with stress post-
curing, which promote delamination and warping of the sample.
For further material development, carbohydrate-based polymers were also
synthesized, in order to explore their feasibility with microstereolithography
technique to further enhance the diversity of the technique. The glycopolymers was
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successfully fabricated on the Desktop machine but further development during
fabrication is needed in order to tackle the stress problem of the cured sample.
In summary, the highly hydrophilicity of PEG and an active site of PEG chain
for easily modification through a variety of synthetic reactions has make PEG an
interesting and robust biomaterials for hydrogel.  With more knowledge and
understanding in the tailoring the polymer properties, structure and mechanism during
polymerisation, the development of novel materials that are able to fabricate on the
microstereolithography technique will be very exciting. This will open up more
possibility of new application of hydrogel in tissue engineering field and offer an
alternative option to patients.
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CHAPTER 6
Preparation and Fabrication of Ceramic Tissue Scaffolds via
Envisiontec Desktop
6.1 Introduction
This chapter describes the development of photo-curable polymer ceramic resins
employing different calcium phosphates for 3D manufacture. Three types of calcium
phosphate have been used; synthesised calcium pyrophosphate (CPP-A), as-received
calcium phosphate (CPP-B) and hydroxyapatite (HAP). The influence of particle size,
composition, and viscosity of calcium phosphate within the photopolymer resin has
been studied.  Thermal degradation of the green body parts was carried out using
thermogravimetrical analyser (TGA) to determine the sintering temperature of the
composite. The fabricated biocomposites were also characterized by X-ray diffraction
(XRD), and scanning electron microscope with X-ray elemental analysis (SEM-
EDAX). The mechanical properties of the different biocomposites were studied and
the formations of apatite layer onto the surface of the materials were determined in
bioactivity test.
6.2 Materials and Methods
In this chapter, three types of calcium phosphate were studied and characterised:
1. Synthesised calcium pyrophosphate, Ca2P2O7 (CPP-A);
2. As-received calcium pyrophosphate from Sigma-Aldrich, Dorset, UK
(CPP-B);
3. Hydroxyapatite from Plasma Biotal Limited, UK (CAPS).
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Properties and method of preparations for each calcium phosphate is discussed in the
next sections.
6.2.1 Preparation of Ceramic Suspension
6.2.1.1 Synthesise of calcium pyrophosphate (CPP-A)
Calcium pyrophosphate (CPP-A) was synthesised at the School of Chemical
Engineering, University of Birmingham [232]. The brushite cement was synthesized
by combining β tricalcium phosphate (β-TCP) with 3.5 M phosphoric acid (H3PO4 )
(Fisher Scientific, Dorset, UK) containing citric acid at a concentration of 50 mM
(Fluka, Dorset, UK) (equation 6.1). The β-TCP was mixed with H3PO4 solution in
powder form, to a liquid ratio (P:L) of 1.25 g/mL. The resulting paste was cast into a
polytetrafluroethylene (PTFE) split mould to form cylindrical samples of diameter 6
mm and height 12 mm.
The cylinders were allowed to harden at 37°C for 24 h prior to testing or
further heat treatment. The hardened cement cylinders were subsequently sintered at
temperatures between 400 and 1200°C for 5 h using a muffle furnace (CWF 1300;
Carbolite, UK), the heating and cooling rate of the furnace was set at 10°C/min
converting the brushite cement into monetite and then calcium pyrophosphate ceramic
(Ca2P2O7) in accordance with equation 6.2 and 6.3:
− ( ) + + 6 → 3 . 2 (6.1)
2 . 2 → 2 + 4 (6.2)
2 → + (6.3)
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The hardened cylinders CPP were then crushed with a pestle and mortar into a
powdery form. Upon crushing, the CPP’s powder was then ball milled with Luckham,
Multimix Major, [TM] for 24, 48 and 72 hours in order to get superfine particle size
of less than 10 µm. Calcium pyrophosphate from Sigma-Aldrich, Dorset, UK (CPP-
B) and hydroxyapatite with the commercial name of CAPTAL ®S from Plasma
Biotal Limited (CAPS), UK, were obtained and ball milled as well for comparison
purposes. To study the effect of ball milling to the particle size of the calcium
phosphate, the distribution of calcium phosphate powder was characterised with a
Mastersizer 3000 (Malvern, UK).
6.2.1.2 Ceramic suspension
The photopolymer resin consists of precursor monomers; dipentaeryolacrylate and
hexanediol ethoxylate diacrylate and Bisphenol A as reactive diluents. The polymer
component of the suspension was prepared prior to mixing with the ceramic. The
formulation in table 6.1 was chosen as the optimum formulation based on previous
study in Chapter 5. The polymer, monomer and photoinitiator were purchased from
Sigma Aldrich, UK whilst the dye was from Kremer Pigmente, Germany.
Table 6.1 Optimum formulation of photo-curable polymer resin.
Abbreviation Ratio (%)
Monomer Dipentaeryolacrylate DPA 60*
Reactive
diluents
Hexanediol ethoxylate diacrylate HDeDA 30*
Bisphenol A BPA 10*
Photoinitiator 2-benzyl-2-(dimethylamino)-4’-
morpholino-butyrophenone
PI 3*
Dye Orasol ® Orange G 0.5**
*: base on the weight of the polymer/monomer
**: base on the weight of the ceramic
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The liquid components were mixed and stirred on a magnetic stirrer for 15
minutes. The percentage of the ceramics powder was varied from 50-150 wt% of
polymer weight, where every 10 wt% of ceramic powders was added to the
suspension every 15 minutes. Dye with 0.5 wt% of ceramic filler was added before
leaving the suspension stirring for 24 hours. The photoinitiator was added and stirred
for 1 hour prior to testing or used in the manufacturing process.
6.2.2 Viscosity measurement
Measurements were carried out in a Size 25 capillary viscometer of from Cannon
Instrument, Cole Palmer, UK (Figure 6.1). By using the equations printed in the
ASTM D 446 standard, the viscometer constants of Cannon-Fenske can be calculated
at temperatures other than those at which the viscometers were calibrated.  The
following equation permits the calculation of the viscometer constant C at any
temperature from a viscometer constant determined experimentally at another
temperature.
C= (1−B [ − ]) (6.4)
= the viscometer constant when filled and tested at the same temperature
T = temperature, °C
B = the temperature dependence factor
t, = values at the test temperature
f  = fill temperature
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The following procedure was used when measuring the viscosity (this is in
accordance to ASTM D445, D446 and ISO 3104, 3105 standards [2-3]):
1. The viscometer was cleaned using suitable solvents, and by passing clean, dry,
filtered air through the instrument to remove the final traces of solvents.
Periodically, any traces of organic deposits were removed with chromic acid
or non-chromium cleaning solution.
2. To charge the sample into the viscometer, the instrument was inverted and
suction was applied to tube L, immersed tube N in the liquid sample, and drew
liquid to mark F. After cleaning the arm N, the instrument was turned to its
normal vertical position.
3. The viscometer was placed into the holder, inserted and aligned vertically into
the constant temperature bath.
4. Approximately 10 min was given to allow the sample to come to the bath
temperature at 40 °C and 15 min at 100°C.
5. The liquid was drawn slightly above mark E, suction was applied to tube N.
6. To measure the efflux time, the liquid sample was allowed to flow freely down
past mark F, measured the time for the meniscus to pass from mark E to mark
F.
7. To ensure consistent and persistent reading, step 5 and 6 were repeated.
8. The kinematic viscosity in mm2/s (cSt) of the sample was calculated by
multiplying the efflux time in seconds by the viscometer constant.
η′ = At (6.5)
where η′ is the kinematic viscosity, A is the viscometer constant (cSt/sec), and
t is the efflux time in seconds. The viscometer constants, A at 40 °C and 100
°C are 2.540 and 2.528 mm2/s2, (cSt/s) respectively.  The S.I. unit of viscosity
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is 1 pascal second (ps), and is equal to 10 poises. One centistokes is equal to
one millimetre squared per second (mm2/s).
Figure 6.1 Schematic diagrams of Cannon-Fenske Routine Viscometer for
Transparent Liquids [234].
6.2.3 Determination of decomposition Temperature
To determine the decomposition temperature of the calcium pyrophosphate
suspension, 90 wt% of CPP-B was mixed in the polymer matrix and acted as a
controlled sample for the measurements. The formulation is shown in Table 6.2.
Table 6.2 Composition of ceramic suspension for sintering temperature determination.
Calcium
Phosphate
Weight %
(wt%) i
Photopolymer
Resin
Ratio (%)ii
CPP-B 90 *HDeDA
*DPA
*BPA
PI
Dye
70
20
10
3a
0.15b
i : weight percent of total weight of prepolymer (*)
ii: ratio based on total weight of prepolymer (*)
a : weight percent of PI based on the total weight of prepolymer (*)
b: weight percent based on the weight of ceramic added to the total weight of
prepolymer (*)
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A 3 mm thickness, dumbbell shaped test piece was fabricated using the
Envisiontec Desktop machine. The dumbbell shaped was then cut into small chunks
and about 15 mg of the chunks were used in the Simultaneously Thermal Analysis
(STA), Polymer Labs STA1500 for thermogravimetrical analysis (TGA). TGA is used
to characterise the decomposition temperature of polymer and ceramic phase
respectively. Three different heating rates; 2°C/min, 10°C/min and 20°C/min were
chosen to investigate effect of different heating rates on the decomposition
temperature. The heating was tested between 25–1000°C in air and at a flow rate of
50 mL/min.
The crystalline composition of the sintered ceramics, from TGA analysis, was
verified by X-ray diffraction (XRD) using a Philips 1820 diffractometer fitted with a
quartz Johansson monochromator operating in subtractive transmission mode at 50
kV and 40 mA. The ceramic was ground and placed on the sample holder.  X-
radiation was pure monochromatic Cu Kc ( λ= 1.54056 Ab ) over a 2θ range of 10 –
70° at  room temperature, using a step size of 0.020° and a step time of 0.9 s. From
the X-ray diffraction (XRD) patterns the relative proportions of CPP and HAP were
determined using relative peak intensity. The crystalline phases were deduced from a
comparison of the registered patterns according to the Joint Committee on Powder
Diffraction Standard (JCPDS) (JCPDS 9-432 for hydroxyapatite, JCPDS 9-169 for β-
tricalcium phosphate, and JCPDS 9-346 for calcium).
SEM micro- graphs and analysis by EDAX of the composites were also
studied using an SEM (Model Carl Zeiss Sigma), with an EDX unit with an
accelerating voltage of 20 kV and magnification 500 x up to 2000x. For SEM-EDAX
analysis, if the Ca/P ratio of the material is lower than 1.67, it decomposes into β-
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tricalcium phosphate and hydroxyapatite, and if the Ca/P ratio is higher than 1.667 it
decomposes into calcium oxide and hydroxyapatite. If the Ca/P ratio is lower than 1.5,
it decomposes into β -tricalcium phosphate and calcium pyrophosphate.
6.3 Characterisation of Ceramic Composite
6.3.1 Determination of sintering temperature and time
It is important to determine the sintering temperature and time as they affect the
microstructure and composition of the resulting ceramic, which contributes to the
properties of the material.  Ceramic discs of calcium phosphate (5 mm height x 4 mm
diameter) were designed and fabricated via the Envision Desktop®. In order to
determine the sintering temperature of the ceramic composite, different heating
profiles were designed based on the analysis from TGA and XRD. The sintering time
was varied over 5-20 hours and sintering temperature from 600 – 1300°C.
The mass, height and diameter changes before and after sintered of the
ceramic discs were measured to provide linear shrinkage. The mass loss and volume
shrinkage are given as follows:
(%) = x 100 (6.6)
Where is the mass loss from the ceramic upon sintering, is the mass of green
body and the mass of the sintered ceramic.
(%) = x 100 (6.7)
Where is the volumetric shrinkage, is the volume of greenbody and is the
volume of the sintered ceramic.
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The density of the samples was measured using a Micromeritics 1330
AccuPyc Pycnometer. The machine uses helium as a medium because helium atoms
are small, ergo  are able to penetrate very small pores within the ceramic to a limit of
0.1 nm [4-5]. This gives an accurate measurement of the volume of the ceramic,
which in turn gives the true density of the material.
6.3.2 Porosity measurement
The porosity of the sintered ceramic was determined by using the gravimetric method
(GM) and Micromeritics 1330 AccuPyc Pycnometer. The calculation consists of the
evaluation of the structural porosity by measuring the effective density. This is
achieved by measuring the size parameters and the weight of the scaffold as follows:
= ,, (6.8)
= (6.9)
The true density is measured from the Pycnometer. Then, the porosity, P, was evaluated
by subtracting the relative density from 1.
= 1 − (6.10)
6.3.3 Mechanical Characterisation
6.3.3.1 Compressive Test
Bones play a major function in the mechanical support of the body weight and endure
lots of stress during motion. Any biomaterial development as a bone replacement
must have optimal mechanical properties, as they are exposed to compression and
shear stresses. A simple compromise on the stability of a bone replacement could lead
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to the collapse of a reconstruction trauma, recurrence of the deformity and even
increased implant morbidity [237]. It is important to investigate the mechanical
behaviour of a newly fabricated biomaterial, especially for biomaterials produced by a
sintering process.  Thermal processes, such as sintering, could exhibit numerous
surface and internal flaws, which act as stress concentrators and lead to compression
failure [238].
Compressive test samples, for each formulation of ceramic compound, were
prepared similar to the sintering study. The compressive strength was measured with a
universal testing machine (Instron 5569, Instron Corp., Canton, MA) with a crosshead
speed of 0.1 mm/min.
The compressive stress of the sintered ceramic (σc) can be calculated in accordance
with the equation:
= 4μ (6.11)
where F is the load at failure (N) and d is the diameter of the ceramic sample (mm).
6.3.3.2 Bioactivity Test
In order to study the bioactivity, samples were soaked in simulated body fluid (SBF)
[239] at body temperature (37 °C) and pH=7.4 for several periods. The SBF has a
composition similar to human blood plasma and has been extensively used for in vitro
bioactivity tests [239]. Table 6.3 presents the ratio of ion concentrations of the
simulated body fluid and human blood plasma.
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Table 6.3 Ion concentrations of the simulated body fluid and human blood plasma
[239].
Ion Concentration (mmol/dm
3)
Simulated body fluid (SBF) Human blood plasma
Na+ 142.0 142.0
K+ 5.0 5.0Mg2+ 1.5 1.5Ca2+ 2.5 2.5Cl- 147.8 103.0HCO3- 4.2 27.0HPO42- 1.0 1.0SO42- 0.5 0.5
For each period, the pH value of the sample was measured with an Automatic
Potential Titrator (China). Three samples were prepared for every scaffold and the
reported pH was the average of the three samples. After soaking, specimens were
taken from the fluid, rinsed with deionised water, and dried at 37 ℃ for SEM
connected with energy dispersive spectroscopy (SEM-EDAX), Model Zeiss Sigma,
UK.
Planimetric procedure (also known as the Jeffries’ Method,) was used. This is a
grain counting method employed to determine the grain size of a composite by
following Section 9 of ASTM E112-10 [240]:
a) Inscribe any shape of known area, A, on an image magnification, M.
b) Count the number of grains that are completely within the area.
c) Count the number of grains that are partially within the area.
d) Divide the results from (c) by 2.
e) Add the result from (d) to the result from (b).
f) Divide the result from (e) to the grains/in2 at 100 x magnification.
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g) Use the definition of ASTM grain size number to determine the grain size,
n.
From definition, grain size can be express as follow;= 1 + = 1 + 3.32 log (6.12)
6.4 Results and Discussion
6.4.1 Particle size and distribution
Table 6.4 summarises the results obtained from the measurements of particle size
(from an average of three repeat measurements). As expected, milling time has a
significant effect on the distribution and particle sizes of the calcium phosphate. After
24 hours, the size has been reduced due to particle fracture, which was caused by the
high energy impacts of the ceramic balls during milling. However, after 48 and 72
hours, the ceramic powders started to agglomerate and stick on the vial wall and the
ball surface, consequently reducing the powder volume, as collection was difficult.
Author decided to exclude the 48 and 72 hours powder for particle size and
distribution measurement.
Table 6.4 Properties of calcium phosphate used in the study.
Sample Particle Size (μm)
Abbreviation 0 h 24 hours
Calcium pyrophosphate (Synthesized) CPP-A 14 4
Calcium pyrophosphate ( Sigma-Aldrich) CPP-B 119 35
Hydroxyapatite CAPS 7 5
Table 6.4 show the effect of milling time on the distribution of the particle size
for each calcium phosphate. It shows that the optimum milling time for the production
of the smallest calcium phosphate powder was 24 hours. Further milling time for 48
hours has induced agglomeration and unfavourable in preparing of a ceramic
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suspension. For CPP-A, 24 hours of milling time exhibited 3 broad peaks covering the
size range 1.2 to 60.00 μm, with the largest peak believed to arise mainly from
particle agglomeration.
Figure 6.2(b) shows the broad peak of particle size distribution of calcium
pyrophosphate from Sigma-Aldrich. The broad peak only shifts to the left after 24
hours, indicating that milling time only gives a significant effect to the distribution of
the particle size from 119 to 35 μm, but not the percentage of a particle’s volume.
This is believed to be attributed to the bigger structure of the calcium pyrophosphate,
as shown in Figure 6.2 (b), and presumably due to the synthesization of CPP in a
well-established and controlled environment.
CAPS hydroxyapatite, received from Biotal Plasma, also had the same
distribution of particles size. The as-received CAPS was synthesized and
manufactured to a size of 5µm, and milling time does not produce any significant
effect on the size of the hydroxyapatite particles, as the particles size distribution only
differs by 1 µm. Surface morphology of each calcium phosphate showed a clear
difference in particle size after 24 hours of milling. This has demonstrated that 24
hours of milling time is sufficient to reduce the particle size and was used throughout
the whole project.
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(a)
(b)
(c)
Figure 6.2 Particles size distribution and surface morphology (magnification of 500x)
of (a) CPP-A, (b) CPP-B and (c) CAPS before and 24 hours milling time.
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6.4.2 Determination of decomposition temperature
The decomposition thermal cycle was optimised based on the TGA studies of
the cured green bodies. Based on Figure 6.3 (a), there are two steps of pyrolysis.  The
first decomposition temperature is HDeDA; around 410 °C and the second onset
temperature is DPA at about 500 °C (Figure 6.3 (b)). The increase in heat flow within
the ceramic is associated with the decomposition of HDeDA, DPA, photoinitiator and
the dye.
(a)
(b)
Figure 6.3 TGA/DTG analysis of (a) 90CPP-B ceramic composite and; (b) HDeDA
and DPA.
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With different heating rates, the decomposition temperature will change
significantly. Figure 6.4 illustrates the TGA/DTG for 2, 10 and 20 °C/min.  As the
heating rate is increased, the onset of decomposition is moved from 380 °C to 370
°C., whereas for the slower heating rate, the thermal degradation occurs at 310 °C. At
2 °C/min, the peak for heat flow is broad and prominent, due to the slow
decomposition rate of polymer chain.
Figure 6.4 TGA and DTG for 90CPP-B at different heating rate.
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Figure 6.5 XRD analysis of 90CPP-B composite at difference temperature.
XRD analysis was done at the different decomposed temperatures to confirm
the crystalline composition of the sintered CPP-B. Figure 6.5 shows that the
amorphous CPP-B has changed into crystalline phase at peak 26.6°, 27.7° and 29.5°
(2θ). The XRD analysis of CPP-B at different temperatures was found to contain β-
TCP as well as β-Ca2P2O7. This shows the complete removal of the polymer phase
and the existence of CPP-B in the sintered composite.
6.4.3 Heating profile
The heating profile, as defined by the TGA/DTG analysis, was used throughout this
study. Apart of complete removal of the polymers phase, this cycle also avoids
deformation and the appearance of air bubbles or cracking in the sintered sample. The
sintering temperature was varied at 600, 800, 1200 and 1300°C and holding time for
each temperature was varied to 3 hours (Figure 6.6).
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Heating profile:
Figure 6.6 Heating profile designed to determine the sintering temperature and holding
sintering time
Table 6.5 Shrinkage of polymer composite after sintering at different temperatures for
3 hours.
Sintering Temperature (°C) Shrinkage (%)
Mass Height Diameter Density
600 Brittle and crumble
800
1000 75 28 22 140
1200 75 28 23 140
1300 Melted
After sintering at different temperatures, the shrinkage of each composite was
measured, as shown in Table 6.5. Figure 6.7(b) shows the final 3D structures after
sintering at 600 and 800°C.Here the composites had difficulty in holding their
integrity, as they were brittle and crumbling. As expected, the low temperatures were
insufficient to reduce the surface free energy, for these grain sizes, to diffuse to the
neighbouring powder particles and increase the density of the composites.
On the other hand, when the temperature was increased from 1000°C to
1200°C, the integrity of the composites improved, as clearly shown in Figure 6.7 (d)
and (e). In order to further improve the density of the composite, the composites were
held for 12 hours and at 1200 °C, and then increased to 1300 °C and held for 3 hours.
This resulted in total glassy phase change of the composites, as shown in Figure 6.6
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(g) and (h) respectively, due to the formation of a glass phase from TCP and calcium
pyrophosphate above 1280 °C.
Figure 6.7 Effect of temperature and holding time on the polymer composite before
and after sintering; (a) resin, (b) green body, (c) 600°C for 3 hours, (d) 800°C for 3
hours, (e) 1000°C for 3 hours, (f) 1200°C for 3 hours, (g) 1200°C for 12 hours, (h)
1300°C for 3 hours.
Figure 6.8 shows the effect of sintering temperature on the morphology of the
composites. At 1000°C, very little sintering has taken place. The phosphate particles
appeared not to be adhered or adsorbed to each other. There was a significant
difference in the surface of the ceramic held at 1200 °C for 3 hours (Figure 6.8 b); the
surface was smooth and completely sealed with a small pore size. When the holding
time was increased to 8 hours, as shown in Figure 6.8 (c), the pore size increased, the
particles looked rounder and necking appeared. This micrograph shows the starting
point of phase changing; from ceramic phase to glassy state, as discussed previously.
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(a)
(b)
(c)
Figure 6.8 SEM micrograph for: (a) 1000°C for 3hours, (b) 1200°C for 3 hours and
(c) 1200°C for 8hours with a 1000x magnification.
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For the further development of the ceramic composite study, CPP-A, CPP-B
and HAP with different ceramic loadings were prepared in order to find the new
biomaterial with optimal properties required as a tissue scaffold. Based upon the
finding from the sintering temperatures and time determinations, a new heating
profile, to improve the microstructure and properties of the ceramic scaffold, was
designed.  The sintering temperature was maintained at 1250°C, but varied in
sintering time from 5-20 hours. Table 6.6 shows the recipe for the ceramic
suspension.
Table 6.6 Composition of ceramic suspension.
Calcium
Phosphate
Weight %
(wt%) i
Abbreviation Photopolymer
Resin
Ratio (%)ii
CPP-A 50
70
100
50A
70A
100A *HDeDA
*DPA
*BPA
PI
Dye
70
20
10
3a
0.15b
CPP-B 50
70
100
50A
70A
100A
HAP 50
70
100
HAP50
HAP70
HAP100
i : weight percent of total weight of prepolymer (*)
ii: ratio based on total volume of prepolymer (*)
a : weight percent of PI based on the total weight of prepolymer (*)
b: weight percent based on the weight of ceramic added to the total weight of
prepolymer (*)
Heating profile
Room temperature 300°C 500°C 1250°C
10°C/min     (1 hr) 2°C/min   (1hr)     2°C/min    RT1, RT2,
RT3, RT4
RT5
where RT1, RT2, RT3, RT4 and RT5 was 5, 7, 10, 12, and 20 hours respectively.
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The design of heating profile was based on the DTA/ TGA analysis for 90wt%
CPP ceramic composite in Figure 6.3. From the TGA graph, the polymer phase
started to decompose 315°C and continues to around 600°C. From the TGA graph, the
polymer phase started to decompose 315°C and continues to about 600°C. The slower
heating rate of 2°C/min and 1 hour holding time, at the decomposition temperature of
the phase, caused massive volume reduction of the green bodies via a chemical
reaction, as shown on the DTA graph. Therefore the mass loss from the ceramic phase
is expected to be unchanged with increasing sintering temperature.
6.4.3.1 Effect of sintering time on density and shrinkage volume of calcium
phosphate
Table 6.7 Volume shrinkage of calcium phosphate for difference sintering time (10
data for each formulation).
Sample Volume Shrinkage (%)
RT1 RT2 RT3 RT4 RT5
CPP-50A 4 5 4 4 4
CPP-70A 3 5 5 5 5
CPP-100A 4 3 4 4 4
CPP-50B 3 5 5 3 3
CPP-70B 3 5 3 3 3
CPP-100B 4 5 4 3 4
CAPS-50 5 5 3 3 2
CAPS-70 5 5 3 4 3
CAPS-100 5 5 4 4 5
As the decomposition continued to 1250 °C, the crystals present within the
ceramic matrix grow and the pores within the crystals decrease, which affects the
shrinkage volume in the ceramic. However, increasing the sintering time does not
give significant effect on the volume of shrinkage of the calcium phosphate, as shown
in Table 6.6. This could be attributed to the appearance of a β-TCP peak as the
sintering time increases, as shown in Figure 6.5.
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On the other hand, Figure 6.9 shows a linear relationship between the true
density and an increase in sintering temperature. True density is the mass of particle
divided by its volume and it this work it was measured by Pycnometer. Changing the
loading of the ceramic ratio also significantly affects the density, as the sintering time
is increased. For instance, the density of the green body CPP-100A increases by 80%
after sintering for 5 hours. In addition, increasing the sintering time from 5-20 hours
also increases the density of CPP-100A to 45%.
Figure 6.9 Density of different ratio of CPP-A, CPP-B and CAP for different   heating
profile. The error bars is the standard deviation of five data obtained for each samples.
The numbers in the green bar chart are the density for CPP-100A, whereas the orange
in colours are for CAPS100.
The porosity in Table 6.8 was quantified by GM methods and is reported as a
function of the sintering time. The results show that with an increase in sintering time
the ceramic porosity is increased. As the sintering time is increased, the neck
formations become apparent as more particles become diffused to the neighbouring
powder particles. The necks then merge and shrink resulting in a change of grain
shape and formation of interconnected pores along the particle junctions [241].
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Table 6.8 Effect of sintering time on the porosity of the ceramic composite.
Sintering Time Porosity (%)
CPP-A CPP-B CAPS
50 70 100 50 70 100 50 70 100
RT1 (5 hours)
RT2 (7hours)
RT3(10 hours)
RT4 (15 hours5
hours)
RT5 (20 hours)
47
49
55
61
73
48
51
56
63
73
51
53
61
66
78
57
63
66
71
76
59
65
64
74
78
63
66
71
76
78
22
25
31
33
34
18
27
29
35
37
23
28
33
37
41
Standard deviation
CPP-A CPP-B CAPS
50 70 100 50 70 100 50 70 100
RT1 (5 hours)
RT2 (7hours)
RT3(10 hours)
RT4 (15 hours5
hours)
RT5 (20 hours)
3
2
3
1
3
2
2
3
1
3
3
3
2
1
1
2
3
3
3
1
3
2
2
2
2
3
1
1
1
2
2
1
1
3
1
3
3
2
1
1
2
2
3
1
2
The pores interconnectivity is well defined and consequently affects the
microstructure of the composite (Figure 6.10). By increasing the sintering time from 5
to 20 hours, the grain size increases greatly to 7.99 µm from 5.52 µm whereas the
density increases to 3.98 g/cm-3 from 2.74 g/cm-3 as shown in Figure 6.11.
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(a) (b)
(c)
Figure 6.10 Surface morphology for CPP-A after sintering for (a) 5 hours, (b), 12
hours and (c) 20 hours (1000x magnification).
Grain growth can be expressed by equation 6.13 [242]:
− = exp − (6.13);
where G and G0 are the average grain size after and before sintering, is the
kinetic grain growth exponent, T is the sintering temperature, t is the sintering time, Q
is the apparent activation energy for grain growth, Ko and R are constants. According
to this grain-growth model, CPP grains have more time to grow with a longer
sintering time. These results coincide with the increase in average grain size and
density of CPP as sintering time increased.
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Figure 6.11 The grain size and density of CPP-A with different sintering times. The
error bars is the standard deviation of three data obtained at each sintering time.
Figure 6.12 shows the XRD pattern for CPP-A sintered at 1250 ̊C for different
times. After increasing the sintering time to 5 hours, the XRD peak for the α-Ca2P2O7
phase change and intensify especially at the range of 26 – 30 ̊C and 42-47 ̊C. The
synthesised CPP-A was amorphous at 27.5 ̊C, and then the peak becomes sharper to
reflect the phase transformation to crystalline α-Ca2P2O7. In addition, after 5 hours
sintering time, the appearance of β-TCP, has increased the density of the polymer
ceramic and this is in good agreement with the increase in density, as discussed
above. Figure 6.11 shows that as the sintering time was increased, the crystals become
denser and the particle size increases.
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Figure 6.12 XRD pattern for CPP-A at different sintering time.
Figure 6.13 XRD pattern for HAP at different sintering time.
In comparison to this, Figure 6.13 shows no changes in diffraction pattern for
HAP suggesting that there is no change in crystalline composition, or in the structure
of the calcium phosphate. This shows that the compound is still calcium phosphate as
the sintering time is increased at 1250 ̊C.
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6.4.3.2 Effect of sintering time on compressive strength and young’s modulus of
calcium phosphate
The compressive strength and elastic modules were determined from the stress–strain
relationship. Figure 6.14 shows the effect of increasing sintering time on the
compressive strength and Young’s modulus for various compositions of calcium
phosphate. The compressive strength increases as the density increases, which is in
agreement with the increase of density, as shown Figure 6.9. It can be observed that
for CPP-100A, the true density increased from 31% to 91% when the sintering time
increased from 5 to 20 hours. As a consequence, the compressive strength of CPP
sintered for 20 hours is higher than that of samples sintered for 5 hours. The
volumetric shrinkage could also be linked to the ceramic densification, which also
could influence the compressive strength of the sintered ceramic.
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(a)
(b)
Figure 6.14 Effect of sintering time on the (a) compressive strength and (b) Young’s
modulus of different ratio of calcium phosphate ceramic composites. The error bars is
the standard deviation of ten data obtained at each sintering time.
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Figure 6.15 Effect of sintering time on the compressive strength of different ratio of
synthesised calcium pyrophosphate (CPP-A) and as-received calcium
pyrophosphate (CPP-B) composites. The error bars is the standard deviation of ten
data obtained at each sintering time.
Figure 6.15 represents the effect of sintering time on the compressive strength
for different ratios of synthesised calcium pyrophosphate (CPP-A) and as-received
calcium pyrophosphate (CPP-B) composite. With extending the sintering time from 5
to 10 hours, the compressive strength increases significantly for both types of CPP,
with an increase in CPP loading. For instance, the compressive strength for CPP-
100A with 100 wt% ceramic loading has increased to 39% of strength after sintered
from 5 hours to 10 hours, whereas for CPP-100B it has increased to 70% of strength.
Furthermore, increasing the sintering time from 10 to 20 hours resulted in the
compressive strength reducing to 3.4 ± 1.0 MPa. This decrease is believed to be
associated with the presence of micro-cracks in the surface morphology of samples
sintered between 12 and 20 hours. Tetragonal to monoclinic phase transformation
occurs at 1200 ̊C, but in this study the transformation may only occur after sintering
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for 12 to 20 hours at 1250 ̊C. Figure 6.16 (a) and (b) shows the apparent micro-cracks
for both samples respectively. As the sintering time is increased, the neck formation
becomes apparent as more particles become diffused, resulting in crystallite growth.
Higher porosity could also contribute to the reduction the integrity of the composites.
(a) (b)
Figure 6.16 Surface morphology of the polymer composite after sintered for 12 and
20 hours respectively show the apparent present of the micro-cracks
(magnification 2000x).
From this work we can observe that CPP-A exhibits a higher compressive
strength than CPP-B. This is due to differences in particles size and distribution, as
CPP-A has a higher mean volume of smaller particle sizes as compare to CPP-B. The
bigger particle size distribution for CPP-B (Figure 6.2 (b)) has resulted in
agglomeration, as the ceramic loading increased during preparation of the ceramic
suspension and subsequent fabrication. Consequently, this contributes to the lower
compressive strength. Backscattered secondary electron (BSE) analysis on the
composition of CPP-A and CPP-B has shown the difference in distribution of both
calcium phosphate powders, in the polymer matrix, of the green body structures
(Figure 6.17). BSE is used to detect a contrast between areas with different chemicals
and is used here to identify the difference between calcium and polymer matrix.
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These results are in strong agreement with the viscosity measurements of the ceramic
suspension.
(a) (b)
Figure 6.17 Comparison of backscattered electron analysis of CPP-A (a) and CPP-B
(b).
(a) (b)
(c)
Figure 6.18 Surface morphology for polymer ceramic at different sintering time; (a) 5
hours, (b) 12 hours and (c) 20 hours prepared from HAP suspension.
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The surface morphology of the polymer ceramic HAP, has shown the most
apparent transformation as the sintering time increases from 5 hours to 20 hours
(Figure 6.18). HAP is well known to have a higher surface energy. The high diffusion
rate resulting from this high surface energy gives rise to better inter particle contact
and increases the elastic modulus of the composite [243]. At 5 hours (Figure 6.18 (a)),
the surface of HAP is mostly closed, with the surface showing a rounding of particles
and early stage neck formation. And as the time increases pores start to interconnect
and the angular-necking shape become highly visible. At 20 hours of sintering, the
interconnected pores evolve to pore closure and further crystal densification, which
contributes to the increased of mechanical properties
Any new biomaterial developed as a bone replacement should have
mechanical strength similar to the natural bone, to maintain integrity until the new
tissue regenerates. The compressive strength and Young’s modulus of cancellous
bone has been reported over a wide range between 4-12 and 20-500 MPa respectively
[116]. In this study, the compressive strength of all CPP ceramic composite and HAP
ranged from 1.7 MPa to 6.7 MPa and Young’s modulus between 10 MPa and 45 MPa.
The results suggest that it may be possible that different types of calcium phosphate
could meet the mechanical requirements and support new bone tissue regeneration
when implanted in the body, especially if the patient is not putting significant burden
on the scaffold. Therefore in order to provide a clinical application for the formulated
ceramic composite, a study on the vitro degradation of the composite was performed.
The addition of calcium phosphate coupled with a high temperature sintering
and a longer sintering time has a significant effect on the mechanical properties
exhibited by the bioceramic. The successful fabrication of a novel bioceramic
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polymer composite with µSL technique offers the possibility of designing complex
tissue scaffolds with optimum mechanical properties for specific tissue engineering
applications.
6.4.3.3 Bioactivity of polymer ceramic
SEM analysis demonstrates the strong influence of sintering time on the
microstructure and morphology of the ceramic composites, as discussed previously. It
can be seen that as the sintering time increases, the formation of microporosity
becomes prominent and their connectivity offers good potential for cell attachment
and proliferation.  The variation of pH value relative to soaking times in simulated
body fluid (SBF) of composite is shown in Table 6.9.
Table 6.9 Variation of pH value in SBF for CPP-70A sintered at RT3 (10 hours). The
standard deviation was obtained from three data at each sintering time.
Soaking time (days) pH reading (±0.01)
0 7.43
1 7.51
4 7.54
8 7.61
The increasing pH value during the first day is believed to be due to the partial
dissolution at the surface level, indicating the high reactivity of these materials. These
shows the interchange between Ca2+ and H3O+ during the formation of the apatite
[244]. This interchange increases the pH level as the immersion time increased,
consequently encouraging the formation of apatite nuclei on the CPP and HAP
surfaces. Figure 6.19 shows that the gradual development of apatite formation on the
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surface of CPP-70A for RT3 (sintering of 10 hours) as a result of increasing the
number of days of immersion in SBF to 1, 4, and 8 days respectively.
(a)                                                                             (A)
(b) (B)
(c) (C)
Figure 6.19 SEM micrograph of CPP-70A after soaking for (a) 1, (b) 4 and (c) 8 days.
A, B and C represent their EDAX analysis respectively.
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Figure 6.19 shows that as the soaking time increases, there were
distinguishable changes on the surface morphology of the samples. After soaking the
CPP-70A in SBF for 8 days, there was an abundance of leaf-like depositions with
lengths of  ̴ 10 µm. These were evenly distributed over the surface of the samples,
proving nucleation of apatite layer. The presence of large pores amongst the leaf-like
crystallite indicates the effect of immersion and corrosion. The calculated Ca/P ratio
is about 1.76, which is close to the theoretical value of stoichiometric HA
(Ca/P=1.67), and Ca/P ratio of the human bone, as it ranges between 1.6 and 1.7
depending on the age of the person.
Table 6.9 shows that the value of Ca/P ratio has increased from 1.20 before
immersion to 1.30 after immersion confirming growth of an apatite layer on the
surface, which is confirmed by the EDAX analysis in Figure 6.19. The higher peak
intensity of Ca after 8 days, explained the higher ratio Ca/P, as Ca ions are used for
the re-precipitation process of HAP large particles [245]. These results were in
agreement with the increase in sample weight, as the immersion period was raised
(Figure 6.20), which can be attributed to the formation of apatite. On the other hand,
the decrease in peak intensity of phosphorous, as shown in Figure 6.19(A), (B) and
(C), is believed to be due to the loss of phosphorous during sintering, as phosphorous
could be escaping from the surface of the sample as gaseous oxides, when being
sintered in air [246].
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Figure 6.20 Weight of the RT3-CPP-70A after immersion in the SBF solution for 1, 4
and 8 days. Three data was obtained at each period.
Table 6.10 Spectral calcium and phosphorous concentrations with their corresponding
Ca/P ratios.
Day
Sintering time
10 hr 20 hr
Ca (wt %) P (wt %) Ca/P Ca (wt %) P (wt %) Ca/P
1st 57.14 42.86 1.33 52.89 47.11 1.12
4th 63.26 36.74 1.53 55.45 44.55 1.24
8th 64.81 35.19 1.76 57.43 42.57 1.31
Table 6.10 shows the spectrum of calcium and phosphorous concentrations,
with their corresponding Ca/P ratios for 10 and 20 hours sintering time. This table
shows that the Ca/P values for 20 hours are less when compare to 10 hours sintering
time. The EDAX analysis has shown the low peak intensity of Ca and P, as shown in
Figure 6.19(C).  The small ratio of Ca/P has resulted in less formation of apatite on
the composite surface. After 8 days in SBF medium, the apatite deposited on the
surface of composite (RT5 CPP-70A) appeared as sub-micrometer crystals. The
composite structure showed signs of immersion and corrosion, as were indicated by
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the reduction in pore size and shrinkage of composite surface area, as shown in Figure
6.21(b).
A distinct difference of apatite formation, for both sintering times, could be
seen in Figure 6.21(a) and Figure 6.19(c). At 10 hours of sintering time, the leaf-like
particle formed on the sample morphology whereas after 20 hours, the morphology
appeared to be granule-like. This has shown the significant effect of sintering time on
the ceramic morphology.
(a) (b)
Figure 6.21 Surface morphology of RT5-CPP-70A for (a) pre-immersion and (b) post
immersion and (c) EDAX analysis for post immersion of the composite sample after 8
days in SBF solution.
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By comparison, the surface morphology of RT5-CPP-70A (Figure 6.21
(b)) has similarities to RT3-CPP-70A (Figure 6.19 (a)), which was immersed in SBF
medium for 1 day. This suggests that for longer sintering times; the formation of
apatite presumably only could occur if the immersion time was longer. Based on SEM
and EDAX analysis on the composite samples, increasing the sintering time has a
significant effect on the bioactivity of the samples, which contributes to the
mechanical properties of each of the composites.
6.5 Conclusion
In this study it was shown that it was possible to synthesize a new photopolymer resin
filled with calcium phosphate powder and to fabricate calcium pyrophosphate
ceramics of defined architecture via a microstereolithography technique. The
formation of Ca2P2O7 ceramic was confirmed using XRD, TGA and DTA analysis.
Different sintering times were designed in order to study its effect on the mechanical
properties and microstructure of the composites. With low sintering times of 5 to 10
hours, the compressive strength increases significantly for both types of CPP as well
as with increasing the CPP loading. However, further sintering time for 12 hours
induced micro-cracks on the particles surface, which was responsible for decreasing
the mechanical properties of the composites. Nevertheless, the compressive properties
of the heat treated composite were quite close to those of cancellous bone (2–17
MPa).
In addition, XRD and SEM-EDAX confirmed the occurrence of apatite on the
surface of ceramic composites. A study on sintering times has provided significant
insight into the re-precipitation and microstructure of apatite formation, which
coincided with the surface morphology shown in the SEM images. Increasing the
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sintering time was expected to enhance the apatite nucleation onto the composite
surface. Finally, novel ceramic composites prepared from calcium phosphate have
bioactivity properties that could be used in bone substitutes and tissue engineering
applications.
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CHAPTER 7
Polymer Ceramic Structure Fabricated via 3D Extruder .
7.1 Introduction
To date the fabrication of three dimensional tissue scaffolds has attracted a lot of
attention from the science community. This is due to their ability to manufacture and
then seed the resultant structure, which combined can make the creation of an natural
artificial organ a reality. There is also a significant demand for synthetic tissue or
bone replacement materials used for tissue engineering due to limited numbers and
the side effect arising from autograft or allograft transplant. Direct manufacturing,
such as microstereolithography and 3D printing are amongst the techniques that are
capable of producing complex and high resolution microstructures, via an additive
layer-by-layer process. It allows the material scientists and physicians to design and
rapidly produce  custom-made scaffolds or implants by taking anatomical information
of the patient’s target defect (e.g. scan, MRI images) and created on a CAD machine
[247].
Currently, synthetic bone replacement materials, based on calcium phosphates,
are widely explored due to its similarity with natural bone. Furthermore, their material
properties can be engineered to suit the mechanical and physiologic demands of the
host tissue by controlling the volume fraction, morphology and arrangement of the
reinforcing phase [151]. Calcium phosphates, such as HAP, is interesting to study
because of its stoichiometric similarity to the inorganic part of natural bone [1-3]. A
composite, for a bone tissue replacement, should have high initial strength and
tailored initial elastic modulus close to the elastic modulus of bone. Polymer on its
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own are low in mechanical strength and stiffness, whereas ceramics are brittle and
ductile. Biomaterials with combination of polymer and ceramic could confer
favourable mechanical properties, toughness and plasticity via the polymer phase and
inherent higher stiffness and strength of the ceramic phase. Detailed information on
polymer composites has been discussed in Chapter 3.
The advancement and versatility of 3D printing has opened up abundant
opportunity for the researchers to fully utilise the technology in tissue engineering
applications. 3D printing technology is based on additive layer manufacturing (ALM)
methods is an alternative process to microstereolithography. The base materials could
be powder, synthetic polymer or polymer composite. 3D parts are created by a layered
printing process according to sliced cross-sectional computer-assisted design (CAD)
and extruded through a nozzle as molten plastic. The process is repeated layer by
layer until the part is complete [248]. Figure 7.1 shows the schematic diagram of a 3D
Extruder nozzle moving in x-y direction to create outlines of each layer according to a
CAD file.
Figure 7.1 Schematic diagram of the 3D Extruder technique.
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This chapter is dedicated as a preliminary study and to explore hydroxyapatite
(HAP) as a candidate precursor in 3D printing. A 3D Extruder manufactured by Bits
from Bytes, UK was purchased and polycaprolactone (PCL)/ hydroxyapatite (HAP)
was prepared and fabricated on the 3D Extruder for further investigation.
Commercially, BFB 3000 3D Extruders (Figure 7.2) use thermoplastics such as
acrylonitrile butadiene styrene (ABS) and polylactic acid (PLA) as a precursor or
polymer feeder. It is one of the most convenient and versatile extruding machines due
to its user friendly operation conditions, wide choices of polymer feeder and the
ability to produce scaffolds without any binders. Figure 7.3 shows the wide choice of
polymer feeder offer by the manufacturer. In addition, the cost for single head printer
machine is less than ₤ 2 000; which give it an advantage when compared to other type
of rapid prototyping techniques such as envisionTEC Desktop; which cost more than
₤ 10 000.
In Chapter 6, envisioTEC Desktop machine successfully fabricated ceramic
composite up to 100wt% of ceramic loading. However, the composite has had
reproducibility problem and suffered stress-post curing which affect the properties of
the composites. This preliminary study was undertaken to assess the feasibility of the
machine to fabricate photopolymer resin with higher loading of ceramic particles.
This could open up the possibility or its potential as a fabricating tool for tissue
engineering applications.
168
Figure 7.2 BFB 3000 3D Extruder from Bit by Bytes, UK
Figure 7.3 Wide selection of polymers feeder as starting materials for BFB 3000 3D
Extruder such as acrylonitrile butadiene styrene (ABS) and polylactic acid (PLA)
(http://www.bitsfrombytes.com).
7.2 Materials and Methods
7.2.1 BFB 3000 3D Extruder
BFB 3000 3D Extruder was purchased from Bit by Bytes, UK and shown in Figure
7.2. The machine offers a simple and direct fabricating method, where it heats the
biopolymer above its glass transition temperature to give the material a paste-like
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consistency and applying pressure through the extruder or print head. The extruder
then pushes out a very fine plastic thread which is applied layer by layer according to
x and y co-ordinates, building a solid, 3D object. It is important to maintain shear-
stress on the material while it is being layered to ensure continuity of the process.
Table 7.1 represent the specification of the machine.
Table 7.1 BFB 3000 3D Extruder specification provided by manufacture Bit by Bytes,
UK.
Maximum built size
X axis
Y axis
Z axis
Z axis resolution
275 mm
275 mm
210 mm
0.125 mm (125 µm)
Print tolerance
X and Y axis
Z axis
±0-1% of object dimension or ± 0.2 mm
(whichever is greater)
± half the processed Z resolution
Print speed extruded volume Maximum 15mm3 per second print and
polymer dependent
Maximum operating temperature at
extruder tip
280°C
7.2.2 Composite filament preparation
Composite filament was prepared by a researcher at Microelectronic and Biosensor
Laboratory, University of Warwick. HAP was dispersed in dichloromethane (DCM),
(Sigma Aldrich, UK) and stirred for 1 hour. Polycaprolactone (PCL) was then
dissolved in the HAP suspension and stirring continued at 80 °C. After 1 hour, the
DCM was evaporated from the mixture on a glass plate and the resultant HAP/PCL
composite film was placed into a water bath at 100°C. At regular intervals, the
HAP/PCL composite was removed from the water bath and rolled between two glass
plates. The procedure was repeated until a solid composite filament of 3 mm diameter
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was achieved (Figure 7.4). 100 and 200wt% of HAP were prepared as for a
preliminary study.
Figure 7.4 Composite filament of 100wt%HAP/PCL with 3 mm in diameter.
7.2.3 Ceramic composite printing
The 3 mm filament of the HAP/PCL composite was placed into the extruder of the
BFB 3000 3D Extruder. The head temperature was set to 200°C and printing was
commenced without any modification to the Extruder. Upon completion of printing,
the printed objects were allowed to cool to room temperature and removed from the
build platform with a scalpel. To investigate the feasibility of the machine, a dumb-
bell shape structure was printed. The dumb-bell was characterised with
thermogravimetrical analysis (TGA) under a flow of air with heating rate of 10°C/min
using a Pyris Diamond, Perkin Elmer (UK) in order to find the decomposition
temperature of the composite. The sintering process was performed in a furnace,
Lanton Thermal Designs Limited (LTD, UK).
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7.3 Results and Discussion
A dumb-bell shape composite with 100wt% HAP was successfully fabricated with the
BFB 3000 3D Extruder as shown in Figure 7.5. This shows the feasibility of the
machine to fabricate a 3D structure of polymer ceramic. Figure 7.6 represent the TGA
for the composite.
(a) (b)
Figure 7.5 (a) Green body of 100wt%HAP/PCL in dumb-bell shape is an exact replica
of the dumbbell-shape’s drawing .
Figure 7.6 Thermogravimetrical analysis (TGA) of 100wt%HAP/PCL composite
The onset decomposition temperature for the composite was found at 350°C
with 50% of residue. The decomposition temperature for HAP/PCL composite was
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found to be at the same range of calcium pyrophosphate (CPP-B/HDeDA) composite
at 370°C as discovered in Chapter 6. Therefore, the same heating profile used for
CPP-B composite was used for the new composite fabricated via the 3D Extruder as
shown below:
Room temperature 300°C 500°C 1250°C
10°C/min     (1 hr)   2°C/min (1hr) 2°C/min (10hours)
After sintering at 1250°C for 10 hours, the structure of dumb-bell test pieces
were disintegrated and brittle. Figure 7.7 clearly shows the failure structure of the
sample.
(a) (b)
Figure 7.7 The disintegrated dumb-bell structure after sintered for 10 hours at 1250°C;
(a) top view and (b) side view.
The unsatisfactory result on the sintered structure is presumably due to the air
trapped between layered fabrications. Based on the machine specification in Table
7.1, the maximum print speed of extruded volume is 15mm3/sec and it depends on the
type of polymer feeder. Presumably, for polymer composite, the print speed could
have been reduced due to higher shear stress in the nozzle cause by the ceramic filler.
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The slower printing speed has allowed more air to trap between layers and
consequently affect the ability of the composite to hold the structure after sintering.
A bulk composite filament was prepared to test the hypothesis. After preparing
the 3 mm composite filament, it was diced with cutter about 5mm to produce a bulk
cylinder shape sample as shown in Figure 7.8.
1
Figure 7.8 The cylinder structure of composite filament.
The diced filaments were then sintered to a ‘gentler’ heating profile in order to
see the ability of the sample to hold its structure. The new heating profile was as
follows:
Room temperature 240°C 550°C 1250°C
1°C/min 0.2°C/min 5°C/min (10hours)
Figure 7.9 Composite of bulk filament samples
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The samples were unable to hold the integrity of the shape even under gentler
heating rate as shown in Figure 7.9. At slower heating rate, the degradation of
polymer phase also occurred at slower rate and eventually collapsed and lost the
shape. At the same time; according to grain-growth model, HAP grains have more
time to growth in the collapsing structure of the composite and as a result; an odd
shape of sintered composite was produced.
Due time constraint, the author could not continue the investigation to further
characterise the ceramic composite. It is interesting to characterise the scanning
electron micrograph (SEM) of grain growth and the structure of the ceramic with
XRD analysis in order to study the affect of using ‘gentler’ heating rate. Heating
profile for the sintering process could be improved by performing a faster heating rate
(1°C/min) at the range of polymer decomposition temperature (300-500°C) in order to
give the ideal time for the grain growth of ceramic to hold the structure whilst
polymer phase slowly degrade. The mechanism of grain growth and the mechanism of
degradation can be further investigated.
As an alternative, process ability of the polymer ceramic during extrusion
could be improve by optimising the formulation of polymer ceramics. This is to
reduce the shear stress during extrusion, which gives significant effect on the green
body of the composite during sintering. One way to overcome the stress is to produce
nano-size ceramic particle and induce chemical treatment on the ceramic particle to
homogenise the size of the ceramic particles and optimise the viscous-elasticity of the
polymer ceramic. Figure 7.10 shows the capability of BFB 3000 3D Extruder to
fabricate custom-made tissue scaffold from 100wt%HAP/PCL. This shows the
feasibility of the machine to fabricate new biopolymer materials and also offering a
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better alternative approach in designing tissue scaffold for specific tissue engineering
applications.
Figure 7.10 A layer by layer structure of polymer ceramic (100wt% HAP/PCL)
fabricated via BFB 3000 3D Extruder.
7.4 Conclusion
Unlike microstereolithography technique, BFB 3000 3D is low in cost and there are
varieties of polymer feeders available from the manufacturer; which are suitable for
wide field of application. In addition, the simpler operation and more robust machine
has had attracted the author to develop novel materials specifically for tissue
engineering application. A bulk composite filament was prepared from 100 and
200wt% HAP and 3D structure of polymer ceramic composite was successfully
fabricated with BFB 3000 3D extruder. However, obtaining a ceramic composite after
sintering the green body was not possible even though a much gentler heating rate
was performed. Nevertheless, the author believe with further optimisation of the
polymer ceramic formulation; coupled with ideal heating rate, a custom-made 3D
structure of tissue scaffold is achievable in the near future.
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CHAPTER 8
Conclusion and Further Work
8.1 Overview
Research in the field of tissue engineering has been exciting and fascinating due to the
dramatic advances in the fields of biochemistry, cell and molecular biology, genetics,
biomedical engineering and materials science over the past decades. Amongst the
objectives of this work is to improve the health and quality of life for millions of
people worldwide by restoring, maintaining, or enhancing tissue and organ function.
One of the key ways that this is being achieved is through the combination of material
science, engineering and cell therapy. The advancements in direct manufacture has
compliment this revolution in tissue engineering.
Microstereolithography has been one of the direct manufacture techniques that
have attracted a lot of attention, due to its precision in fabricating complex 3-D
microstructures with high-aspect ratio. The limited supply of biomaterial resins for
microstereolithography has driven researchers to find novel materials and to improve
the performance of this technique.
8.2 Project Objective
In this study, a range of new bio-compatible/degradable materials that are compatible
with a commercial 3D direct manufacture system has been explored. There were three
stages involved in this project (as presented in Chapter 1) and the conclusion for each
stage is summarised:
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8.2.1 The development of a stereolithography system for the optimal formulation
of biodegradable photopolymer resin to fabricate 3D scaffolds with controlled
microstructures specifically for soft tissue engineering applications such as
hydrogels.
In this study, two types of equipment were developed in order to allow some
understanding on the techniques and process involved in microstereolithography. A
light projector was developed from a decommissioned Envisiontec Perfactory® Mini
and UV light engine was built from high power ultra-bright LED array.
Commercial resin (envisionTec’s R11) was successfully cured on the Light
Projector but the layer-by-layer formation was limited due to the presence of a
photoinhibitor in R11. On the other hand, the Enfis light engine system was
specifically designed to fabricate a 3D structure from formulated photo-curable
ceramic suspensions. A 3D structure was successfully fabricated from 70wt%
hydroxyapatite (HAP)/1, 6 hexanediol diacrylate (HDDA) suspension. The
development of both systems was limited due to the absence of a Z-stage. For future
work, the addition of a Z-stage into these systems (especially the Enfis system) could
produce a promising system. Nevertheless, the decommissioned Light projector and
Light engine have given abundance of knowledge and clear understanding on the
principle of microstereolithography techniques.
An important finding in this study was the optimisation of dumb-bell sample
size and dimension for materials characterisation on the Deben Microtensile machine,
which was used for all measurement in this project, in order to obtain reliable and
precise measurements.
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8.2.2 The development of a range of new bio-compatible/degradable materials
for soft tissue application that is compatible with a commercial 3D direct
manufacture system (Envisiontec Desktop).
The objective of this section was to investigate the feasibility of the commercial
machine to fabricate novel biomaterials. In this study, a new photopolymer resin with
different types of multifunctional acrylate polymer was successfully fabricated on a
commercial 3D direct manufacture system, envisionTEC Desktop. Table 8.1 shows
the formulated photopolymer resin.
Table 8.1 Formulation of multifunctional acrylate for photopolymer resin.
Monomer/polymer Ratio (%)
Diethylene glycol diacrylate (DEDGA)
Dipentaerythritol penta-/hexa-acrylate (HDPA)
90
10
Trietyleneglycol diacrylate (TEGDA)
Dipentaerythritol penta-/hexa-acrylate (HDPA)
90
10
Polyethylene glycol diacrylate (PEGDA)
Dipentaerythritol penta-/hexa-acrylate (HDPA)
80
20
Photoinnitiator and dye for each formulation: 3.75 wt% and 0.15 wt% of the
polymer weight respectively.
Mechanical characterisation was performed on the fabricated hydrogels to
investigate the properties and their possible application. The polymerised formulation
hydrogels exhibited degradation properties, which is a vital requirement for a
biomaterial that promise potential for the use of this resin for soft tissue scaffold
applications. However, the hydrogels suffered with stress post-curing, which promote
delamination and warping of the sample.
Even though the hydrogels faced the problems mentioned above, the
formulated photopolymer resin allowed the exploration/functionalization of these
resins by investigating the addition of a carbohydrate groups to the polymer system
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for biomedical application of hydrogels. This is to explore the feasibility of the
microstereolithography technique to fabricate new photopolymer resin for further
enhance its diversity. The formulation of new photopolymer resin is shown as in
Table 8.2.
Table 8.2Formulation of glycopolymers photopolymer resin
Sample Ratio (%)
PEGDA HDPA *GlcAc
Control
2.5Glc
5.0Glc
70.0
72.5
70.0
30.0
25.0
25.0
-
2.5
5.0
*: 1,2,3,4,6-Penta-O-acetyl-beta-D-glucopyranose; Acetyl 2,3,4,6-tetra-o-
acetyl-beta-D-glucopyranoside
The glycopolymer resin was successfully fabricated on the machine and was
characterised to study the effect of carbohydrate group to the formulation. The
modification and increases of GlcAc has increased the molecular weight of the
polymer mixture and as a result increased the swelling ratio of the cured polymer. The
addition of GlcAc also assists in the erosion process during degradation. However,
sugar-based glycopolymers has no significant effect on the tensile strength of the
cured polymers due to reoccurring stress post-curing on the samples.
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8.2.3 The optimal formulation of polymer ceramic resin compatible with a
commercial 3D direct manufacture system (envisionTEC Desktop) specifically
for hard tissue engineering applications such as bone.
In this study, three types of calcium phosphate have been used; synthesised calcium
pyrophosphate (CPP-A), as-received calcium phosphate (CPP-B) and hydroxyapatite
(HAP), as part of a new synthesized photopolymer resin. It was shown that a 3
dimensional ceramic composite structure can be fabricated on an EnvisionTEC
Desktop machine. It has been shown that particle size, composition, and viscosity of
calcium phosphate within the photopolymer resin have a significant effect on the
decomposition temperature and porosity of the polymer composite. Table 8.3
represent the polymer ceramic resin prepared in this study.
Table 8.3 Formulation of photopolymer ceramic resin for fabrication on envisionTEC
Desktop.
Calcium
Phosphate
Weight %
(wt%) i
Abbreviation Photopolymer
Resin
Ratio (%)ii
CPP-A 50
70
100
50A
70A
100A *HDeDA
*DPA
*BPA
PI
Dye
70
20
10
3a
0.15b
CPP-B 50
70
100
50A
70A
100A
HAP 50
70
100
HAP50
HAP70
HAP100
i : weight percent of total weight of prepolymer (*)
ii: ratio based on total volume of prepolymer (*)
a : weight percent of PI based on the total weight of prepolymer (*)
Different sintering times were designed in order to study its effect on the
mechanical properties and microstructure of the composites. The mechanical strength
of both type of CPP ceramic were found to increase with increasing sintering times
from 5 to 10 hours at 1250°C. Generally as sintering temperature is increased the
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compressive strength was increased but after 12 hours, micro-cracks were induced on
the particles surface. On the other hand, the elastic modulus of the HAP-based
composite increased as the sintering time increased. This is due to the small particles
size and high diffusion rate between particle contacts during the sintering process.
Nevertheless, the compressive properties of the heat treated composite were quite
close to those of cancellous bone (2–17 MPa) [116].
In bioactivity study, increasing the sintering time has enhanced the apatite
nucleation onto the composite surface. A study on sintering times has provided
significant insight into the re-precipitation and microstructure of apatite formation that
could be used in bone substitutes and tissue engineering applications.
As a preliminary study, a 3D extruder machine (BFB 3000 3D extruder) was
used to study the feasibility and the potential of the machine as a tool for
manufacturing a 3D polymer composite for tissue engineering application. A
composite filament of polycaprolactone (PCL)/ hydroxyapatite (HAP) was
successfully fabricated on the machine. However, further study on the sintering
temperature has to explore in order to obtain a 3D ceramic composite for tissue
engineering application.
8.3 Future Work
For future work in the development of biodegradable photopolymer resin for soft
tissue application, the temperature during photopolymerisation should be taken into
account. An increasing in temperature could affect the gel formation of the
photopolymer resin due to increased polymer chain termination. Early crosslinking of
the polymer network could occur at certain temperatures and as results a cured layer is
formed. The thickness of the cured layer could affect the penetration depth of light
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into the photopolymer resin. If a layer is not cured deep enough, the interlayer
bonding fails and delamination occurs [136].
Another possible area for future study is to enhance the mechanical properties
of the biodegradable biopolymer. One way to address this is increasing the
crosslinking density of the polymer by increasing the macromer concentration or
decreasing the macromer molecular weight. In addition, higher density of crosslinking
network  could also increase the time for network degradation, as it decreases the
water diffusion and increases the number of bonds that must be cleaved to break the
network into water-soluble components [249].
For development of polymer ceramic resin, characterisation on particles size
and dimension of calcium phosphate can be further investigated in order to overcome
the agglomerate during preparation of the ceramic suspension. Backscattered
secondary electron (BSE) analysis on the composition of CPP has shown that the
difference in distribution of particle size in the polymer ceramic. Surface modification
or treatment on the ceramic particles should be explored in order to produce uniform
particles size and distribution in ceramic suspension. Ribeiro et. al has successfully
prepared porous ceramic microspheres as injectable bone-filling materials and drug
delivery matrices [163]. It would be interesting to investigate the possibility to
prepare microsphere calcium phosphate as filler in a photopolymer resin for
microstereolithography fabrication.
The effect of sintering temperature on the mass loss and volumetric shrinkage
of the sintered ceramic must be explored further in other to determine the shape of the
final ceramic. An extensive study between sintering temperature, ceramic porosity
and pore connectivity is important in the degradation of the material, which will affect
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the apatite formation of the sintered composite. Progressively, in vivo behaviour of the
tissue scaffold should be further investigated to learn the viability, proliferation, and
extracellular matrix production.
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